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ABSTRACT 
Sensory nerves detect conditions in the external and internal environment and permit 
behavioral and physiological responses to maintain homeostasis and ensure survival.  As such, 
sensory nerves detect a wide variety of stimuli including heat, touch, pH, and vibration.  The 
precise nature of these responses is dependent upon the initiating stimulus and site of activation.  
Potentially threatening stimuli (noxious heat, cellular damage, chemical irritants) activate 
nociceptive sensory nerves through the gating of ion channels expressed at sensory nerve 
terminals, thereby evoking defensive reflexes such as cough, watering eyes and limb withdrawal 
as well as sensations of pain or discomfort.  While these responses are typically protective, 
inflammation alters peripheral neuronal activity resulting in unpleasant sensations, and aberrant 
reflexes which are the hallmark symptoms of pulmonary disease(Costello et al., 1999).     
Unfortunately, current treatments which focus on specific symptoms such as 
bronchospasm and inflammation are not effective for all individuals and fail to address underlying 
sensory nerve activity(Barnes, 2012).  Therefore, understanding mechanisms underlying the 
increased activity of ion channels expressed at sensory nerve terminals such as the nonselective 
cation channels transient receptor potential channels ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1) 
may lead to the development of novel therapeutics for the treatment of inflammatory pulmonary 
diseases.    As inflammation induces mitochondrial dysfunction through inhibition of the electron 
transport chain (mETC), we investigated the impact of mitochondrial dysfunction on the activation 
of TRPA1 and TRPV1 using dissociated vagal neurons.   Using live cell Ca2+ imaging to measure 
channel activation, we found that mitochondrial dysfunction induced with antimycin A (complex III 
inhibitor), carbonyl cyanide m-chlorophenyl hydrazone (CCCP, mitochondrial uncoupling agent), 
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and rotenone (complex I inhibitor) activates a portion of vagal neurons expressing TRPA1 and/or 
TRPV1.   
Using antimycin A, we discovered that across all neurons were Ca2+ responses were 
diminished (averaged across all neurons) with knockout/inhibition of either TRPA1 or TRPV1 and 
largely abolished with dual knockout/inhibition of both channels.   Interestingly, the diminished 
response with TRPA1 knockout or inhibition can be attributed to a decrease in the magnitude of 
the Ca2+ flux in neurons responding while decreased responses with TRPV1 knockout or inhibition 
were associated with the decrease in percentage of neurons which responded, not Ca2+ flux 
magnitude.  Mitochondrial dysfunction results in the increased reproduction of ROS and 
mitochondrial depolarization.  Therefore, we evaluated the relationship between mitochondrial 
depolarization (using JC-1) and ROS production (using mitoSOX Red) and channel activation 
(Ca2+ imaging with FURA-2AM).  Although only a portion of TRPA1/TRPV1 expressing neurons 
responded to mitochondrial inhibition with CCCP, rotenone or antimycin A that there was no 
difference in ROS production or mitochondrial depolarization between responding and non-
responding neurons.  
We also investigated the impact of these ROS on the activation of TRPA1 and TRPV1.  
We found that the activation of TRPA1, but not TRPV1, is likely downstream of mitochondrial 
ROS production as 1) antimycin A induced Ca2+ fluxes were diminished by co-treatment with ROS 
scavengers in transfected HEK293 cells and dissociated vagal neurons, 2) ROS production 
(measured with mitoSOX Red  simultaneously with Ca2+  imaging) was correlated with Ca2+  fluxes 
in TRPA1, but not TRPV1, expressing neurons, and 3)  the ROS-unresponsive TRPA1 K620A 
mutant did not respond to antimycin A.  As studies regarding ROS production are hindered by the 
lack of suitable methods to measure ROS production associated with caveats involved in the use 
of ROS sensitive dyes and the lack of sensitivity offered by redox sensitive proteins, we sought 
to increase the sensitivity of roGFP1, a redox sensitive variant of GFP by replacing one of the 
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reactive cysteines with selenocysteine, a more reactive nucleophile.  We successfully produced 
a redox sensing protein with increased sensitivity.  However, this protein exhibited low expression 
levels and a greatly diminished dynamic range. 
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CHAPTER 1 
Introduction 
 
AIRWAY SENSORY NERVES 
The respiratory tract is innervated by sensory nerves which aid in maintaining 
homeostasis, coordinating respiration, and protecting the airways from threats to gas exchange.  
These nerves are classified by the ganglionic location of the cell body.  Bronchopulmonary 
sensory nerves (and other visceral sensory nerves) are vagal nerves as their cell bodies are 
contained in the vagal ganglia which is comprised of both the nodose and jugular ganglia.  
Although the jugular and nodose ganglia are fused in the mouse and closely juxtaposed in 
humans, they have differing embryonic origins as nodose neurons originate placode and jugular 
neurons are of neural crest origin(Nassenstein et al., 2010).  Furthermore, gene expression 
profiles in the jugular and nodose ganglia are distinct(Nassenstein et al., 2010), indicating that 
they perform differing physiologic functions.  Despite these phenotypic and embryonic differences, 
both nodose and jugular portions of the vagal ganglia project nerve fibers along branches of the 
vagus nerve (cranial nerve X) to innervate visceral organs including the lungs.  Activation of these 
vagal sensory nerves stimulates of the nucleus tractus solitarius (NTS) in the brainstem which 
processes sensory information to coordinate responses a wide variety of responses and reflexes 
dependent upon the nature of the initiating stimulus(Canning, 2007).  Thus, activation of 
pulmonary sensory nerves can evoke reflexes including the Hering–Breuer reflex which 
terminates inspiration and initiates expiration as well as defensive reflexes such as cough which 
serve to protect the lungs(Canning et al., 2006; Chou et al., 2008).  To coordinate these responses 
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NTS neurons are part of large neuronal networks, receiving both sensory inputs and inputs from 
higher brain centers(Kubin et al., 2006). In the NTS, these inputs are integrated and processed 
by secondary neurons.  Output form these secondary neurons projects to the parasympathetic 
preganglionic nerves, motor neurons which control the respiratory muscles (larynx, diaphragm, 
glottis, etc.), and to higher brain centers(Bonham et al., 2006).  
Indeed, vagus nerves contain both afferent sensory and efferent parasympathetic nerve 
fibers.  The efferent parasympathetic fibers aid in regulating many bodily functions including heart 
rate, peristalsis, and mucus secretion(Agostoni et al., 1957; Paintal, 1973).  Activation of 
pulmonary efferent parasympathetic nerves triggers mucus production and 
bronchospasm(Canning and Fischer, 2001; Rogers, 2001). As the airway smooth muscle lacks 
sympathetic innervation, these vagal parasympathetic nerves are the primary regulators of 
bronchial tone(Kesler and Canning, 1999; Lewis et al., 2006).  Thus, output can cause 
bronchoconstriction and impair respiration.  While efferent nerves are important to enacting 
responses to stimuli, over 80% of vagal neurons are afferent sensory nerves which detect 
conditions in the local environment(Agostoni et al., 1957; Berthound and Neuhuber, 2000).  
Afferent vagal sensory nerves are classified using several criteria including axon 
conduction speed and type of activating stimuli (ex: mechanical versus noxious thermal stimuli).  
While these classifications are useful in understanding the properties and functions of sensory 
nerves, they are somewhat ambiguous as some neurons fall into intermediate categories.  
However, vagal sensory nerves fall into two main subtypes:  the myelinated, rapidly conducting 
Aβ and Aδ fibers and the unmyelinated, slowly conducting C-fibers.  The Aβ and Aδ fibers are 
low-threshold mechanosensitive nerves and are largely activated by pulmonary stretch generated 
during respiration(Yu, 2005).  Thus, CNS input from these fibers is utilized to aid in respiratory 
control and homeostatic maintenance.  Mechanosensitive nerves are further subdivided into the 
slowly adapting stretch receptors (SAR) and rapidly adapting pulmonary stretch receptors (RAR).  
3 
 
SAR are insensitive to chemical stimuli and respond to pulmonary stretch: exhibiting an increased 
firing rate during pulmonary inflation and a decreased firing rate during pulmonary 
deflation(Adrian, 1933).  Activation of SAR initiates the Hering–Breuer reflex which halts 
inspiration and initiates expiration(Widdicombe, 1954).  In the lower airways, the RAR are also 
activated by pulmonary stretch, as they are activated by changes in pulmonary volume such as 
those observed during inspiration.  However, in the upper airways, the RAR are activated by 
mechanical and chemical stimuli associated with aspiration of food, drink or stomach acid such 
as low osmolality and H+(Widdicombe, 2003; Chou et al., 2008).    Therefore, in the upper airways 
(trachea and larynx) RAR activation can evoke defensive reflexes whereas in the lower airways 
they are largely involved in homeostatic and respiratory regulation(Chou et al., 2008). 
While the RAR detect some threatening stimuli, this is primarily performed by nociceptive 
nerves, which are unmyelinated, slowly conducting C-fibers. Approximately 75% of vagal sensory 
nerves are nociceptive and detect potentially harmful stimuli(Carr and Undem, 2003; Taylor-Clark 
et al., 2015).  Indeed, the lungs are faced with threats from pollution, viral infections, and chemical 
irritants. These stimuli activate nociceptive nerves and elicit centrally mediated defensive reflexes 
such as cough, bronchospasm and mucus secretion to protect the lungs(Lee and Yu, 2014; 
Mazzone and Undem, 2016). Nociceptor activation can also evoke an axonal reflex involving the 
release of neuropeptides.  A small portion of jugular nociceptors express neuropeptides such as 
tachykinins, and calcitonin gene related peptide (CGRP) which are stored in vesicles(Lundberg 
et al., 1984b; Dinh et al., 2003; Yu et al., 2005).  In this subset of sensory nerves, activation 
triggers release of these neuropeptides into surrounding tissues producing local 
bronchoconstriction, mucus secretion and triggering a neurogenic inflammatory 
reaction(Lundberg et al., 1984a; Lou, 1993; D'Agostino et al., 2002; Quarcoo et al., 2004).  Thus, 
inhalation of irritants such as cigarette smoke can evoke both defensive reflexes and 
inflammation(Andre et al., 2008).  However, the importance of the axonal reflex in humans is likely 
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minimal as few neurons express these neuropeptides as compared to model organisms such as 
the guinea pig and rat (Ellis et al., 1997). 
Protecting the lungs requires the detection of many, diverse potentially threatening stimuli.  
The key to this broad sensitivity is the expression of ion channels at the sensory nerve terminals.  
Each of these ion channels is activated by a specific set of stimuli.  Thus, the sensitivity of sensory 
nerves to a specific stimulus is a direct result of the expression of specific ion channels.  For 
instance, nociceptors express ion channels which are activated by potentially threatening stimuli 
as they express ion channels which are activated by potential harms such as noxious heat and 
cellular damage.  Activation of these channels at sensory nerve terminals produces an influx of 
cations and a graded depolarization.  If sufficient in magnitude, this results in sensory nerve 
activation and can evoke defensive reflexes and unpleasant sensations.  Examples of these 
channels include acid sensing ion channels which detect low pH(Kollarik and Undem, 2002) and 
P2X2/3 channels which are activated by extracellular ATP released from damaged cells(Weigand 
et al., 2012).  However, two of the most studied ion channels expressed on nociceptive nerves 
are the nonselective cation channels transient receptor potential channels ankyrin 1 (TRPA1) and 
vanilloid 1 (TRPV1). 
 
TRPA1 AND TRPV1 
TRPA1 and TRPV1 are homotetrameric channels belonging to the TRP ion channel 
superfamily.  Each subunit contains six transmembrane domains, a TRP box, and a cytosolic 
ankyrin repeat domain which mediates protein-protein interactions(Wu et al., 2010a).  Members 
of the TRP ion channel superfamily are expressed on a wide variety of cell types and are activated 
by both chemical and physical stimuli including temperature, stretch, vibration, and osmotic 
pressure(Wu et al., 2010a).  However, TRPA1 and TRPV1 are expressed almost exclusively on 
unmyelinated nociceptive neurons and are activated by threatening stimuli(Caterina et al., 1997; 
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Bessac and Jordt, 2008).  TRPV1 expression is often used to identify nociceptive neurons as it is 
expressed on virtually all nociceptors(Szolcsanyi et al., 1988). TRPA1 is expressed in 39% of 
vagal neurons and is present 66% of vagal neurons which express TRPV1(Michael and Priestley, 
1999; Kobayashi et al., 2005; Nassenstein et al., 2008).  A wide array of potentially threatening 
stimuli activate TRPA1 and TRPV1 resulting in an influx of monovalent and divalent cations 
including Na+ and Ca2+(Tominaga et al., 1998; Bobkov et al., 2011).  If large enough, this 
depolarization results in sensory nerve activation and initiates defensive reflexes and unpleasant 
sensations(Canning et al., 2004; Birrell et al., 2009). Additionally, the influx of Ca2+ can alter 
cellular signaling and trigger the release of neuropeptides.  Thus, activation of TRPA1 and TRPV1 
can trigger both defensive reflexes and neurogenic inflammation(Andre et al., 2008; Boillat et al., 
2014).  Although there are many TRPA1 and TRPV1 are expressed on many of the same nerves 
and both respond to a wide array of threatening stimuli, their regulation and specific sets of 
activating stimuli differ.  
TRPV1 is best known as the “capsaicin receptor” as it is activated by capsaicin, a 
compound in hot peppers(Caterina et al., 1997). However, TRPV1 is polymodal and activated by 
a wide array of noxious compounds including low pH, N-arachidonoyl dopamine and lipoxygenase 
products(Caterina et al., 1997; Hwang et al., 2000; Bessac and Jordt, 2008; Morales-Lázaro et 
al., 2013).  In addition to its function as a ligand gated channel, TRPV1 is thermosensitive as it is 
activated by noxious heat (>43oC)(Caterina et al., 1997).  Interestingly, extracellular H+ increases 
the thermosensitivity of TRPV1, making it active at physiologic temperatures (37oC)(Tominaga et 
al., 1998).  It is believed that the hyperthermia observed during treatment with TRPV1 antagonists 
is due to blocking of this acid sensing function(Garami et al., 2010).  Unfortunately, this has 
hindered the development of TRPV1 antagonists to treat pain disorders and other conditions 
involving the increased activity of TRPV1. The regulation of TRPV1 is complex and involves many 
competing factors including cytosolic Ca2+, phosphatidylinositol 4,5-bisphosphate (PIP2)(Prescott 
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and Julius, 2003), and signaling pathways including the phospholipase C/protein kinase C 
(PLC/PKC) and protein kinase A (PKA) pathways(Mohapatra and Nau, 2005; Lee et al., 2012).  
Interestingly, the PLC/PKC pathway sensitizes TRPV1 through several mechanisms(Rohacs et 
al., 2008).  PIP2, found in the inner leaflet of the cytosolic membrane constitutively inhibits 
TRPV1(Cao et al., 2013).  PLC activation results in translocation to the cell membrane where it 
cleaves PIP2, generating diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3).  Not only 
does this release PIP2 inhibition, but DAG directly activates TRPV1(Woo et al., 2008).  The IP3 
generated during cleavage of PIP2 results in Ca2+ release form the endoplasmic reticulum.  
Together, the increased cytosolic Ca2+ and DAG activate PKC, which phosphorylates and 
sensitizes TRPV1(Vellani et al., 2001; Mandadi et al., 2006b; Wang et al., 2015).   
As with TRPV1, TRPA1 is activated by a wide array of threatening stimuli. Activators of 
TRPA1 include noxious low temperatures (<17oC), phytochemicals (ex: allyl isothiocyanate, AITC, 
in wasabi and allicin in garlic), chemical irritants found in pollution (ex: toluene and O3-)(Story et 
al., 2003; Bautista et al., 2005; Bautista et al., 2006; Bessac and Jordt, 2008; Taylor-Clark et al., 
2009b; Taylor-Clark and Undem, 2010).  In addition to being activated by exogenous compounds, 
TRPA1 is also activated by endogenous electrophilic compounds including reactive oxygen 
species (ROS), reactive nitrogen species (NOS) and 4-hydroxy-nonenal(Taylor-Clark et al., 2007; 
Trevisani et al., 2007; Andersson et al., 2008; Takahashi et al., 2008; Taylor-Clark et al., 2009a).  
This broad sensitivity of TRPA1 is a result of its generalized activation by electrophilic compounds 
which permits the detection of many threats to gas exchange such as smoke, inflammatory 
mediators, pollution and chemical irritants(Macpherson et al., 2007).  The key to this sensitivity 
are highly reactive residues in the cytosolic domain, most notably the cysteine at amino acid 
621(Bahia et al., 2016).  This cysteine forms reversible covalent bonds with electrophiles, 
producing TRPA1 activation (Hinman et al., 2006; Macpherson et al., 2007; Bahia et al., 2016).  
This generalized electrophilic sensitivity results in activation of TRPA1 by most (if not all) 
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electrophiles, even with exposure to minute concentrations. Regulation of TRPA1 is performed 
by several factors including cytosolic Ca2+ and G coupled protein receptors such as the bradykinin 
receptor(Bautista et al., 2006).  Interestingly, TRPA1 is both potentiated and inactivated by 
cytosolic Ca2+:  small increases in cytosolic Ca2+ potentiate TRPA1 while large increases in 
cytosolic Ca2+ inactivate TRPA1(Wang et al., 2008).  
While TRPA1 and TRPV1 are activated by distinct stimuli and regulated through different 
mechanisms, their activity is linked through functional and physical interactions.  Thus, the 
presence and activation of one channel affects the activity of the other channel. Simultaneous 
application of TRPA1 and TRPV1 agonists results in synergistic activation of sensory 
neurons(Hsu and Lee, 2015; Lin et al., 2015).  Furthermore, activation of one channel (TRPA1 or 
TRPV1) produces Ca2+-dependent desensitization of the other.  TRPA1 desensitization resulting 
from TRPV1 activation occurs as a direct result of the elevation of intracellular Ca2+(Ruparel et 
al., 2008).  However, TRPA1 activation-induced TRPV1 desensitization occurs through 
dephosphorylation by the Ca2+-dependent phosphatase calcineurin(Ruparel et al., 2008).  In 
addition to these functional interactions, there is a physical interaction between the TRPA1 and 
TRPV1. It has been suggested that TRPA1 and TRPV1 can form heteromeric channels(Salas et 
al., 2009; Staruschenko et al., 2010) and functional TRPV1::TRPA1 concactomers which are 
sensitive to TRPV1 but not TRPA1 agonists have been generated(Fischer et al., 2014).  More 
recently, it has been proposed that the physical association of TRPA1 and TRPV1 occurs through 
the transmembrane protein tMEM100(Weng et al., 2015).  In the presence of tMEM100, the 
modulation of channel activity is dependent on the presence of one (TRPA1 or TRPV1) vs. both 
(TRPA1 and TRPV1) ion channels(Weng et al., 2015).  As such, tMEM100 acts to increase 
TRPA1 activity in the presence of TRPV1 and decrease the TRPV1 activity when TRPA1 is not 
present(Weng et al., 2015).  At this time, little is known of the precise nature of these interactions 
and the role they play, if any, in the development of disease states. 
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SENSORY NERVE ACTIVITY IN DISEASE STATES 
In inflammatory pulmonary diseases, sensory nerves exhibit increased and aberrant 
activity, possibly due to increased TRPA1 and TRPV1 activation(Hathaway et al., 1993; Caceres 
et al., 2009).  In murine models of asthma, a lower concentration of bronchoconstrictive 
compounds such as methacholine and histamine are required to elicit bronchoconstriction(Lewis 
and Broadley, 1995; Costello et al., 1999).  Individuals suffering from inflammatory pulmonary 
diseases including asthma and COPD exhibit increased sensitivity to inhaled TRPV1 agonists, 
requiring a decreased concentration to elicit cough(Hathaway et al., 1993; Doherty et al., 2000).  
Taken together, indicates a state of sensory nerve hyperexcitability wherein sensory nerves 
exhibit increased activity and are activated by a lower stimulus threshold.  This aberrant activity 
provides increased stimulation of the NTS and evokes excessive defensive reflexes (cough, 
bronchospasm, mucus secretion) and unpleasant sensations (dyspnea).  While typically 
protective, these reflexes become debilitating and form the hallmark symptoms of pulmonary 
diseases.  Interestingly, sensory nerve hyperexcitability and excessive defensive reflexes also 
contribute to the development of other disease states including diabetic neuropathy, and irritable 
bowel syndrome, gastroesophageal reflux disease and bladder dysfunction(Marchand et al., 
2005; Hughes et al., 2013; McMahon et al., 2015).  However, the mechanisms underlying the 
development of hyperexcitability, particularly under the influence of inflammation are poorly 
understood. 
 
INFLAMMATION 
Inflammation from events such as viral infection increases sensory nerve activity and 
produces symptomatic exacerbations of pulmonary diseases(Undem et al., 1999; Lee and 
Widdicombe, 2001; Zaccone and Undem, 2016).  In murine models, inhalation of inflammatory 
agents (allergens) induce inflammation and sensory nerve hyperexcitability(Morris et al., 2003). 
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Further evidence supporting a role for sensory nerve hyperexcitability in disease is that vagotomy 
reverses allergen-induced airway hyperreactivity in response to methacholine(McAlexander et al., 
2015).  Additionally, ablation of TRPV1 expressing neurons prevents ovalbumin induced airway 
hyperreactivity(Trankner et al., 2014), indicating that sensory nerves play a large role in the 
development of pulmonary disease.  However, how inflammation acts to alter their activity is not 
well understood.  Inflammatory states are associated with many changes in the lungs including 
increased ROS, presence of inflammatory mediators, white blood cell infiltration and 
mitochondrial dysfunction(McBride et al., 1994; Braunstahl et al., 2003; Brozmanova et al., 2007).  
Furthermore, eosinophil and ROS levels are correlated with airway 
hyperresponsiveness(Jatakanon et al., 1998). Individuals with inflammatory pulmonary diseases 
have increased levels of pulmonary endogenous inflammatory mediators including H+, 
lipoxygenase products, ROS, prostaglandin E2 (PGE2) and bradykinin(Kharitonov and Barnes, 
2001; Rahman et al., 2002; Braunstahl et al., 2003).  It has been shown that these inflammatory 
mediators, including PGE2 and ROS (H2O2), can increase sensory nerve excitability(Ho et al., 
2000; Lee and Widdicombe, 2001; Ruan et al., 2005).  Not only is this association between 
inflammation and sensory nerve hyperexcitability present in disease states, but it is also present 
in inflammatory reactions arising from injury or infection.  Peripheral injection of proinflammatory 
agents such as Complete Freund's Adjuvant (CFA) or carrageenan induces mechanical and 
thermal hyperalgesia.  This hyperalgesia is greatly diminished by inhibition/knockout of either 
TRPA1 or TRPV1(Davis et al., 2000; Eid et al., 2008; Fernandes et al., 2010).  While TRPA1 and 
TRPV1 are activated and sensitized by many individual inflammatory mediators and singling 
pathways(Carr et al., 2003; Kim et al., 2004; Grace et al., 2012), the role of individual mediators 
and signaling pathways in the development of hyperexcitability during inflammatory states is 
largely unknown.  This opens the possibility that other, overlooked, factors may influence the 
development of sensory nerve hyperexcitability. 
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MITOCHONDRIA 
One of these under-studied factors which may play a role in the development of sensory 
nerve hyperexcitability is mitochondrial dysfunction.  Mitochondria are double membrane bound 
organelles best known for their role in ATP production.  The outer membrane is highly porous and 
permeable to many ions and molecules under 5000 daltons.  The inner membrane encloses the 
matrix and is folded and compartmentalized into cristae. These folds serve to increase surface 
area which is beneficial as the components of the mETC which is used for the generation of ATP 
are contained in the inner membrane.  The initial substrates for the mETC are NADH and FADH2 
which are reduced at complexes I and II (respectively), releasing an electron.  This released 
electron is transferred along a series of electron donors and acceptors to the terminal electron 
acceptor, O2, generating water.  At complexes I, III and IV, the energy generated from electron 
transfer pumps H+ into the intermembrane space between the inner and outer mitochondrial 
membranes.  This generates a negative electrochemical gradient (-150 to -180mV) relative to the 
cytoplasm which is used to drive production of ATP at complex V (ATP synthase).  At complex V, 
the entry of H+ into the matrix drives the reaction between ADP and a phosphate to generate ATP.  
While the mETC is highly efficient, electrons prematurely slip and partially reduce O2 forming ROS 
such as O2- and H2O2.  Although ROS are involved in cellular signaling(D'Autréaux and Toledano, 
2007), they cause cellular damage through the oxidation of proteins and lipids(Radak et al., 2011).  
Therefore, cells express many proteins and molecules such as SOD, Catalase and GSH to 
convert ROS to H2O to prevent cellular damage(Stowe and Camara, 2009).  
While the production of ATP is essential to cellular function, the mitochondria play many 
other roles including regulating Ca2+ homeostasis and coordinating cellular stress 
responses(Wang and Wei, 2017).  Thus, they serve as signaling hubs for pathways involving 
cellular growth, proliferation and stress responses(Chandel, 2014).  Mitochondria are also the 
major source of cellular ROS which not only damages cells via the oxidation of lipids and proteins, 
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but it also serves to regulate cellular signaling(D'Autréaux and Toledano, 2007; Radak et al., 
2011; Forrester et al., 2018).  Inflammatory signaling pathways (TNFα and IL-1β) directly inhibit 
the mitochondrial electron transport chain (mETC) resulting in depolarization, increased ROS 
production, Ca2+ release, and initiating signaling events associated with cellular stress 
responses(Zell et al., 1997; Moe et al., 2004; Mariappan et al., 2009).  This indicates a state of 
mitochondrial dysfunction which can lead to apoptosis; however, this is not always the 
case(Veatch et al., 2009; Guerra et al., 2017).  Although mitochondrial dysfunction is present 
during inflammatory states and correlated with sensory nerve hyperexcitability, the influence of 
mitochondrial function on sensory nerve activity is unknown.  Mitochondria are densely packed at 
sensory nerve terminals whereas axons contain relatively few mitochondria and handle much 
larger electrical currents(Hung et al., 1973; von During and Andres, 1988). This large number is 
likely not required for ATP production as inhibition of ATP synthase does not alter nerve 
behavior(Gover et al., 2007).  However, this large number may serve to amplify the impact of the 
mitochondria on signaling events at the nerve terminal.  
Evidence from clinical studies and animal models also suggest a role for mitochondria in 
the development of sensory nerve hyperexcitability in inflammatory pulmonary diseases.  In 
murine models, mitochondrial dysfunction is correlated with the development of sensory nerve 
hyperexcitability(Mabalirajan et al., 2008).  Asthmatics have an increased rate of specific 
mitochondrial DNA mutations(Zifa et al., 2012).  Lung samples from individuals with inflammatory 
pulmonary diseases and experimental allergic asthma animal models contain mitochondria 
exhibiting morphological characteristics associated with dysfunction, increased levels of ROS and 
altered ROS scavenger activity(Emelyanov et al., 2001; Mabalirajan et al., 2008; Fitzpatrick et al., 
2009; Reddy, 2011; Celik et al., 2012).  In murine models, exposure to allergens such as pollen 
dust triggers ROS production and oxidative damage to mETC chain proteins(Aguilera-Aguirre et 
al., 2009).  Several studies demonstrate that ROS such as H2O2 and O2- can sensitize and activate 
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bronchopulmonary C-fibers(Ho and Lee, 1998; Ruan et al., 2003; Lin et al., 2010).   Several 
clinical studies demonstrate that antioxidant therapy decreases the severity of 
asthma(Gvozdjáková et al., 2005; Mabalirajan et al., 2009).  However, despite this large body of 
evidence suggesting a role for mitochondrial dysfunction in the development of pulmonary 
disease, little is known of its direct impact on sensory nerve activity.   
Inflammatory signaling results in many 
changes in cellular function which may alter 
TRPA1 and TRPV1 activity, to independently 
evaluate the impact of mitochondrial function on 
these channels specific mitochondrial 
modulators such as antimycin A (complex III 
inhibitor), carbonyl cyanide m-chlorophenyl 
hydrazone (CCCP, mitochondrial uncoupling agent), and rotenone (mETC complex I inhibitor) 
can be used (Fig. 1.1).  Our lab has previously demonstrated that inhibition of the mETC complex 
III with antimycin A activates bronchopulmonary C-fibers likely through gating of TRPA1 and 
TRPV1.  Antimycin A and the inhibition of mETC complex III induces mitochondrial depolarization, 
mitochondrial Ca2+ release, and ROS production(Potter and Reif, 1952; Slater, 1973; Reddy, 
2011).  Thus, mETC inhibition results in large-scale changes in cellular homeostasis and signaling 
many of which may serve to activate TRPA1 and TRPV1.  TRPA1 is likely activated by increased 
mitochondrial ROS production as it is highly sensitive to activation by electrophiles, including ROS 
such as O2- and H2O2(Andersson et al., 2008; Takahashi et al., 2008).  Furthermore, as TRPA1 
reacts with electrophiles at a rate far greater than that for cellular antioxidant enzymes, this may 
allow for activation even in the presence of cellular antioxidant enzymes(Bahia et al., 2016).  
However, few studies demonstrate the activation of TRPV1 by oxidizing agents(Taylor-Clark and 
Undem, 2011).  In studies which indicate the involvement of TRPV1 activation by oxidizing agents 
Figure 1.1:  Action sites of specific 
mitochondrial modulators on the mETC 
and inner mitochondrial membrane. 
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used high concentrations (> 1mM) of H2O2(Susankova et al., 2006; Chuang and Lin, 2009). 
Although H2O2 induces sensory nerve hyperexcitability which is partially mediated by 
TRPV1(Ruan et al., 2005, 2006), H2O2 alters cellular signaling pathways including the PLC/PKC 
and NF-ĸB pathways(Cosentino-Gomes et al., 2012; Forrester et al., 2018) many of which 
sensitize and activate TRPV1.  Therefore, TRPV1 activation during mitochondrial dysfunction 
likely occurs via another mechanism, possibly downstream of mitochondrial Ca2+ release.  TRPV1 
mediated sensitization in inflammatory states involves phosphorylation PKC(Ferreira et al., 2005).  
Furthermore, antimycin A can cause the activation and translocation of PKC(Wu et al., 2010b; 
Hadley et al., 2014) as well as mitochondrial Ca2+ release can also activate PLC(Cuchillo-Ibáñez 
et al., 2004).  Taken together, this may induce TRPV1 activation though the production of DAG, 
depletion of PIP2 and phosphorylation by PKC(Wu et al., 2010b; Hadley et al., 2014). 
 
MEASURING TRPA1 AND TRPV1 ACTIVATION 
Much evidence suggests that mitochondrial dysfunction and the increased activity of 
TRPA1 and TRPV1 contribute to sensory nerve hyperexcitability.  However, little is known of the 
direct impact of mitochondria on sensory nerve function.  One reason for this may be the 
requirement to study both mitochondrial function and ion channel activation. Another difficulty is 
the heterogenous nature of vagal neurons and the presence of many cell types in the vagal 
ganglia.  Vagal neurons exhibit differential protein expression thus are functionally distinct.  As a 
consequence, stimulus response differs between individual neurons, making it impossible to 
assay whole ganglia for mitochondrial function or ion channel activation.  Thus, to study 
responses, measurements of individual neurons must be obtained.  This can be achieved through 
using ex-vivo measurements of individual nerve fibers or measurements from dissociated neurons 
on coverslips.  Nerve fiber recordings involve identifying nerve fibers of interest (ex: C-fibers) and 
measuring action potentials generated following ion channel activation.  In dissociated neurons 
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there are two primary methods to measure ion channel activation:  live cell cation imaging and 
electrophysiology.  Electrophysiological methods involve both voltage and current patch clamp 
(whole cell, perforated patch, etc.).  Voltage clamp measures channel activation though 
measuring current (largely Na+) flowing through open ion channels whereas current clamp 
measures voltage changes generated during action potentials.  While electrophysiological 
methods (patch clamp and nerve fiber recordings) are useful in studying activation of TRPA1 and 
TRPV1, obtaining data from a large number of cells is time consuming and labor intensive. 
Additionally, studying the impact of the mitochondria on TRPA1 and TRPV1 activation requires 
additional measurements of mitochondrial function such as mitochondrial depolarization and ROS 
production which are not easily combined with electrophysiological methods.   
On the other hand, live cell imaging allows for simultaneous measurement of mitochondrial 
function (ROS production and mitochondrial polarization) and channel activation as well as the 
collection of data from many cells.  As TRPA1 and TRPV1 are non-selective cation channels, 
their activation results in increased in cytosolic Na+ and Ca2+(Tominaga et al., 1998; Bobkov et 
al., 2011).  Thus, channel activation can be measured using cytosolic Na+ or Ca2+ indicator dyes 
which exhibit altered fluorescence when bound to these ions.  Many such dyes are available, 
each differing in terms of their fluorescent properties (excitation/emission wavelengths), ionic 
specificity (ex:  Na+ vs Ca2+), photostability, cellular loading efficiency, etc.  This diversity of 
indicators allows for the selection of a dye which is best suited for the requirements of each 
individual experiment. As cytosolic Ca2+ is tightly regulated and resting concentrations are 
low(~100nM), TRPA1 and TRPV1 activation evokes a large fold change in cytosolic Ca2+.  
However, Na+ concentrations are less tightly controlled and there is a lower fold change with 
TRPA1 and TRPV1 activation.  This lower fold change in cation concentration makes visualizing 
fluxes more difficult.  Thus, Ca2+ imaging is the preferred method to measure TRPA1 and TRPV1 
activation.  
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While there are many fluorescent cytosolic Ca2+ indicators, one of the most commonly 
used is FURA-2AM as it is highly specific for Ca2+, is ratiometric, has a high fluorescence intensity, 
and its fluorescence is not significantly altered by cellular conditions such as pH.  The key to its 
efficient loading and high cellular retention is that it is bound to two acetoxymethyl (AM) groups 
through an ester bond.  These AM groups make the dye uncharged and membrane permeable.  
Upon diffusing into the cytosol, these groups are cleaved by cytosolic esterases, giving it a 
negative charge, rendering it membrane impermeable which decreases dye leak.   Another key 
benefit of FURA-2AM is that it is ratiometric allowing for reliable measurements even with unequal 
cell loading and experimental irregularities.  While not bound to calcium, FURA exhibits low 
fluorescence with 340nm excitation (510nm emission) and higher fluorescence with 380nm 
excitation (510nm emission).  However, Ca2+-bound FURA exhibits increased emissions with 
340nm excitation and decreased emissions with 380nm excitation.  As such, cytosolic calcium is 
measured using 340/380nm excitation ratio.  While Ca2+ imaging using FURA-2AM is well suited 
to measure TRPA1 and TRPV1 activation, it can also be used to determine whether increases in 
cytosolic Ca2+ arises from an intracellular or extracellular source.  To identify the source of the 
calcium flux, cells are exposed to a buffer lacking Ca2+ or a buffer with Ca2+ buffered to match the 
concentration of cytosolic Ca2+(~100nM).  Thus, in these buffers, ion channel activation fails to 
evoke increased cytosolic Ca2+.  However, if the source is from intracellular, an increase in 
cytosolic Ca2+ will be observed.  Another way to perform these experiments is to block calcium 
entry with a pore blocker such as ruthenium red or gadolinium. 
 
MEASURING MITOCHONDRIAL FUNCTION 
Just as fluorescent indicator dyes can provide insights into channel activation, other dyes 
are available to investigate aspects of mitochondrial function including ROS production and 
mitochondrial membrane potential.  The key to detecting mitochondrial membrane potential is the 
16 
 
cationic nature of membrane potential indicators and the highly negative mitochondrial membrane 
potential (-150 to -180 mV) relative to the cytoplasm.  Thus, these positively charged dyes 
accumulate in the mitochondria via the electrochemical gradient.  When the mitochondria 
depolarize, the negative membrane potential is lost, and the electrochemical gradient is no longer 
sufficient to retain the dye and it diffuses into the cytoplasm.  One such dye, JC-1, forms J-
aggregates at high concentrations in polarized mitochondria which exhibit red fluorescence 
(590nm emission)(Reers et al., 1991).  Mitochondrial depolarization results in the dye diffusing 
into the cytoplasm. Under these conditions (lower concentrations), it is in monomeric form and 
exhibits green fluorescence (525nm emission).  Although this allows for ratiometric 
measurements (red/green) of mitochondrial membrane potential, the J-aggregates require long 
incubation times to reach equilibrium(Perry et al., 2011).  Therefore, measurements of only the 
monomeric form (equilibrium in ~15 minutes) are often used.  
Although measurements of mitochondrial membrane potential provide important insights 
into mitochondrial function, ROS measurements are also essential to assessing the impact of 
mitochondria on TRPA1 and TRPV1 activation.  While many ROS sensitive dyes are available, 
the principle underling ROS detection is similar: unreacted dyes exhibit low fluorescence and 
upon oxidation by ROS florescence increases(Zhang and Gao, 2015).  One useful property of 
these dyes is that they possess varying specificities for different ROS such as H2O2 versus O2-.  
Furthermore, cationic ROS indicators, such as MitoSOX Red, accumulate in the mitochondria 
permitting measurements of mitochondrial ROS while eliminating the influence of ROS from other 
cellular sources(Dickinson et al., 2010).  Unfortunately, most of dyes are neither ratiometric nor 
reversible and there are often caveats to their use.  One such caveat for dihydroethidium the 
requirement for it to bind DNA after oxidation to produce a fluorescent signal(Ortega-Villasante et 
al., 2016).  Another redox indicator, dihydrorhodamine 123, requires the presence a cofactor (Fe2+ 
or cytochrome c) for oxidation to occur(Ortega-Villasante et al., 2016).  One method to measure 
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ROS that avoids many of these caveats is use of genetically encoded redox sensing proteins.  
However, these proteins lack the sensitivity offered by dyes.  
 
INCREASING THE SENSITIVITY OF roGFP1 
Genetically engineered redox sensitive proteins are ratiometric, reversible and can be 
targeted to subcellular compartments such as the mitochondrial intermembrane space and 
endoplasmic reticulum(Hanson et al., 2004; Delic et al., 2010).  Currently available genetically 
encoded redox sensors include redox sensitive green, red, and yellow fluorescent 
proteins(Sugiura et al., 2015).  Their function relies on the reversible reduction and oxidation of 
two reactive cysteines which serve as a biological switch.  Oxidation by ROS results in disulfide 
bond formation which alters protein conformation and fluorescence(Dooley et al., 2004; Hanson 
et al., 2004). Reduction breaks this bond, restoring the protein to its original state(Hanson et al., 
2004). In the case of roGFP1, a variant of redox sensitive green fluorescent protein, 
oxidation/reduction shifts fluorescence between two excitation maxima (405nm and 470nm; 
510nm emission)(Dooley et al., 2004; Hanson et al., 2004).  Thus, cellular ROS production is 
measured using the 405nm/470nm excitation ratio.  While these reversible and ratiometric 
properties make roGFP1 well suited for measuring ROS, it lacks the sensitivity required to detect 
small scale changes in ROS which are involved in cellular signaling events.  One factor 
contributing to the relative insensitivity of roGFP1 is the protonation of its redox-sensitive 
cysteines under physiologic cellular conditions: only deprotonated cysteines are able to react with 
ROS(Roberts et al., 1986).  Several attempts have been made to improve the sensitivity of 
roGFP1 by mutating amino acids surrounding the reactive cysteines decrease their pKa (from 
~8.2)(Cannon and Remington, 2006).  While these changes have improved sensitivity, these 
proteins still lack the sensitivity of redox-sensitive dyes and are unable to measure many 
physiologically relevant changes in ROS production. 
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One potential method to improve the sensitivity of roGFP1 is the use of a more reactive 
amino acid such as selenocysteine in place of one, or both cysteines(Dooley, 2006).  
Selenocysteine is structurally identical to cysteine however, in the place of sulphur it contains 
selenium. This substitution makes it a more reactive nucleophile (pKa of 5.5 vs 8.2)(Byun and 
Kang, 2011). As selenocysteine forms bridges with both itself and cysteine, replacing one or both 
of the reactive cysteines in roGFP1 with selenocysteines should generate a functional redox 
sensor(Müller et al., 1994).  However, selenocysteine incorporation is more complex and 
inefficient compared to insertion of canonical amino acids as its incorporation occurs at UGA 
codons which typically serve to stop protein translation(Chambers et al., 1986).  Thus, 
incorporation requires additional elements including a selenocysteine insertion sequence (SECIS) 
in the 3’ untranslated region of the mRNA and a selenocysteine specific elongation factor.  
However, even in the presence of all required elements, insertion remains inefficient with 
translation stalling at the UGA codon, producing in protein truncation. To increase incorporation, 
selenoproteins can be co-expressed with selenocysteine binding protein 2 (SBP2), which helps 
coordinate the proximity of the required insertional elements(Zinoni et al., 1990; Tujebajeva et al., 
2000). Thus, SBP2 decreases stalling at the UGA codon, increasing insertional efficiency and 
decreasing truncation. Therefore, co-expression of SBP1 with a roGFP selenoprotein should 
permit sufficient expression to measure ROS production in live cell imaging experiments.    
 
LIVE CELL CO-IMAGING 
The many methods available for live cell imaging allows for the selection of an indicator 
dye with specific properties ideally suited for each experiment.  In the case of understanding the 
impact of mitochondrial function on the activation of TRPA1 and TRPV1, this requires the 
simultaneous use of two indicators:  one to measure cytosolic cation fluxes and another to 
measure mitochondrial function.  While traditional live cell imaging employs one dye and 
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measures one aspect of cellular function, the differing spectral properties of these indictors allows 
for the simultaneous use of two indicators(Miyazaki and Ross, 2015).  However, indicators whose 
spectral excitation and emission wavelengths differ are required.  For example: to measure ion 
channel activation and mitochondrial membrane potential, a combination of FURA-2AM and JC-
1 can be used and to measure ROS production and ion channel activation a combination of 
MitoSOX Red and FURA-2AM can be used.  Measurements of the fluorescence of both dyes 
simultaneously can be achieved using sequential excitation of all required excitation and emission 
wavelengths.  Thus, using live cell co-imaging, correlations can be made between ion channel 
activation and mitochondrial function. 
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CHAPTER 2 
Relative contributions of TRPA1 and TRPV1 in the response to mitochondrial inhibition 
 
INTRODUCTION 
Activation of TRPA1 and TRPV1 results in nociceptive sensory nerve activation and 
evokes sensations of dyspnea and defensive reflexes such as cough, bronchospasm and mucus 
secretion(Tatar et al., 1988; Nassenstein et al., 2008; Birrell et al., 2009; Brozmanova et al., 2012).  
Inflammation alters peripheral nerve activity and results in aberrant sensory nerve activity which 
evokes excessive, defensive reflexes which serve no protective function and are detrimental(Lee 
and Widdicombe, 2001).   Much evidence suggests a role for TRPA1 and TRPV1 in the 
development of aberrant sensory nerve activity under the influence of inflammation.  Individuals 
with inflammatory pulmonary diseases have in increased sensitivity to TRPV1 agonists, requiring 
a lower concentration to evoke cough(Nakajima et al., 2006).  Inhibition of TRPA1 decreases 
cough following exposure to inflammatory mediators including PGE2 and bradykinin(Grace et al., 
2012). Furthermore, TRPA1 and TRPV1 are involved in the development of mechanical and 
thermal hyperalgesia in many mouse models of inflammatory pain(Davis et al., 2000; Petrus et 
al., 2007; Fernandes et al., 2010).  Inflammatory states have a profound impact in the lungs 
including a decreased pH, white blood cell infiltration, increased ROS, mitochondrial dysfunction, 
activation of signaling pathways involved in cellular stress responses.  Due to this wide array of 
effects and the polymodal nature of TRPA1 and TRPV1, it is likely that overlooked factors such 
as mitochondrial dysfunction may play a role in the increased activity of these ion channels in 
inflammatory states. 
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Our lab has previously studied the effects of mitochondrial dysfunction on sensory nerve 
activation by using antimycin A(Nesuashvili et al., 2013), a mETC complex III inhibitor which 
inhibits the Qi site on complex III, blocking electron transfer(Potter and Reif, 1952; Turrens et al., 
1985a).  Not only does this inhibit ATP production, but this inhibition also causes mitochondrial 
depolarization, mitochondrial Ca2+ release and increases electron slippage from the mETC.  As 
these released electrons incompletely reduce O2, complex III inhibition results in increased H2O2 
and O2- production(Gyulkhandanyan and Pennefather, 2004; Muller et al., 2004; Stowe and 
Camara, 2009).  As these same events are observed in mitochondrial dysfunction induced with 
inflammatory signaling(López-Armada et al., 2013; Strzelak et al., 2018), this method provides a 
valid approach to studying the effects of mitochondrial function on sensory nerve activity.  We 
found that antimycin A selectively activates nociceptive C-fibers (ex-vivo lung-vagal ganglia 
preparation) and isolated vagal neurons (Ca2+ imaging) which express TRPA1 and/or TRPV1.  In 
isolated vagal neurons, this activation was abolished in the absence of extracellular Ca2+, 
indicating that a plasma membrane Ca2+ permeable ion channel, such as TRPA1 and/or TRPV1 
was involved.  Indeed, both KO and inhibition of TRPA1 and TRPV1 decreased the action 
potential discharge in the ex-vivo lung-vagal prep and decreased Ca2+ fluxes in isolated vagal 
neurons.  These responses were largely abolished with dual inhibition of TRPA1 and TRPV1 in 
isolated vagal neurons.  These findings were confirmed in HEK293 cells as TRPA1 and TRPV1 
transfected but not non-transfected cells as antimycin A evoked a Ca2+ flux in Ca2+ imaging 
experiments and increased current in whole cell patch clamp experiments. 
Here, we further investigated responses antimycin A evoked mitochondrial dysfunction in 
isolated vagal neurons to evaluate the relative contributions of TRPA1 and TRPV1 using live cell 
Ca2+ imaging of dissociated vagal neurons.  These studies are complicated by the co-expression 
TRPA1 and TRPV1 on most nociceptive neurons as well as the functional and physical 
interactions between these two channels.  Not only can activation of one channel affect the activity 
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of the other, but the expression of one versus both channels affects channel activity(Salas et al., 
2009; Weng et al., 2015).  Therefore, it is important to study the contributions of each channel 
using both inhibition and knockout (KO) models.  Given that antimycin A induced responses 
appear dependent on TRPA1 and TRPV1 which are heterogeneously expressed in vagal 
neurons, we have chosen to use VR1 CreRosa which expresses td Tomato in TRPV1 lineage 
neurons to aid in the identification of nociceptive neurons. However, TRPA1 responses in vagal 
VR1 CreRosa neurons have not yet be characterized.  Therefore, we first characterized TRPA1 
responses to establish the feasibility of this approach.  We found that 78% of neurons expressed 
td Tomato with 76% of these td Tomato+ neurons exhibiting a Ca2+ flux during AITC and/or 
capsaicin treatment.  Of the 22% of neurons did not express td Tomato and 18% of these td 
Tomato- neurons responded to ATIC or capsaicin.  Therefore, using VR1 CreRosa neurons, 
nociceptors were defined as being either TRPV1 lineage neurons (express td Tomato) or non-
TRPV1 lineage neurons which responded to AITC (see methods).  However, in KO models this 
method of nociceptor classification is not possible.  Therefore, in experiments using KO mice, 
nociceptors were identified based on the functional responses to AITC (TRPV1 KO) or capsaicin 
(TRPA1 KO).   
Using this method for nociceptor identification, we found that antimycin A activated only a 
portion of nociceptive neurons with non-responding nociceptors exhibiting a response similar to 
that of non-nociceptive neurons.   The Ca2+ influx across all neurons was diminished with TRPA1 
KO, TRPA1 inhibition, TRPV1 KO, and TRPV1 inhibition and further reduced with dual 
knockout/inhibition for both channels.  Interestingly, neither inhibition nor KO of TRPA1 diminished 
the percentage of neurons which responded to Antimycin A.  However, inhibition and KO of 
TRPA1 diminished the Ca2+ flux in responding neurons.  Conversely, inhibition and knockout of 
TRPV1 decreased in the percentage of responding neurons while having no effect on the Ca2+ 
flux in responding neurons.    While large-scare Ca2+ fluxes were isolated to a portion of 
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nociceptive neurons, both non-nociceptive neurons and non-responding neurons also exhibited 
an increase in cytosolic Ca2+, albeit much lower than that for responding neurons.  This influx was 
prevented using the Ca2+ channel blockers GD3+ + Ruthenium red and with extracellular Ca2+ 
buffered to match cytosolic Ca2+ (100mM), indicating the involvement of another plasma 
membrane Ca2+ permeable ion channel.  However, our attempts to block this with inhibition of 
TRPM7, a ROS-sensitive, Ca2+ permeable channel that is expressed on all neurons, were 
unsuccessful.  Therefore, the identity of the channel involved in the small-scale Ca2+ fluxes 
remains unknown. 
 
RESULTS 
Characterization of VR1 CreRosa 
Due to the difficulties posed in the classification of nociceptive versus non-nociceptive 
neurons, we used a VR1 CreRosa mouse model to classify TRPV1 lineage neurons.  This mouse 
model expresses td Tomato in all cells which have ever expressed TRPV1.  Thus, TRPV1 lineage 
neurons can be identified using td Tomato fluorescence.  We found that there was a large Ca2+ 
flux in response to AITC and capsaicin which was largely isolated to neurons expressing td 
Tomato (Fig. 2.1 A and B).  It is important to note that the classification of capsaicin responses 
was complicated by the lack of washout following AITC treatment.  However, 61% of neurons (n 
= 68) expressed td Tomato and responded to AITC and/or capsaicin (Fig. 1.1 C) and therefore 
likely currently express TRPA1 and/or TRPV1.  td Tomato was present in an additional 17% of 
neurons (n = 21) which did not exhibit a Ca2+ flux in response to ATIC or capsaicin. The remaining 
22% of neurons (n = 28) did not express td Tomato.  Of these td Tomato- neurons, only 5 (4% of 
all neurons) responded to AITC or capsaicin.  Taken together, this indicates that classifying 
nociceptors as the population of neurons which is either of TRPV1 lineage (expresses td Tomato) 
or responds to AITC is likely to identify all neurons which express TRPA1 and/or TRPV1. 
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Antimycin A activates a portion of vagal neurons 
To evaluate the relative contributions of TRPA1 and TRPV1 in the response to 
mitochondrial modulation, we first evaluated antimycin A-evoked cytosolic Ca2+ fluxes in VR1 
CreRosa neurons.  As TRPA1 and TRPV1 are non-selective cation channels, their activation 
results in increased in cytosolic Ca2+.  Indeed, antimycin A evoked a large increase in cytosolic 
Ca2+ (averaged across all neurons) (Fig. 2.1 A and B).  Consistent with our hypothesis, these 
responses were isolated to nociceptive neurons, many of which express TRPA1 and/or TRPV1.  
However, only a portion of these neurons responded with nonresponding nociceptors exhibiting 
a response similar to that of non-nociceptive neurons. Indeed, these experiments demonstrate a 
great heterogeneity of responses between responding nociceptors, non-responding nociceptors 
and non-nociceptors (Fig. 2.2 C).  In Fig. 2.2 C, it is important to note that the AITC and capsaicin 
responses were affected by prior exposures which did not return to baseline due to the long time 
periods involved in reversing Ca2+ fluxes.  Therefore, we used the baseline prior to antimycin A 
treatment to calculate responses.   
Figure 2.1:  AITC and Capsaicin responses are largely isolated to td Tomato expressing 
neurons. Time course of cytosolic Ca2+ fluxes in td Tomato expressing and non-expressing 
neurons (A) with the magnitude of Ca2+ fluxes in response to ATIC and capsaicin (b) and 
barograph depicting the percentage of neurons which express td Tomato and respond to AITC 
or capsaicin. 
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Blocking and buffering external Ca2+ 
While large responses were isolated to nociceptive vagal 
neurons, we observed a cytosolic Ca2+ flux of a much 
lower magnitude in both non-nociceptive neurons and 
non-responding nociceptors.  As antimycin A evokes 
mitochondrial depolarization and calcium release, there is 
the possibility that this flux is a result of the release of 
internal Ca2+ stores or the activation of a Ca2+ permeable 
ion channel on the plasma membrane. We investigated 
the source of this Ca2+ flux using two methods:  1) 
buffering external Ca2+ to match the cytosolic Ca2+ 
concentration (100nM) and 2) blocking external Ca2+ with 
the Ca2+ channel blockers Gd3+ + Ruthenium Red. As both these methods prevented the Ca2+ flux 
(p < .05 vs non-nociceptive) (Fig. 2.2 C), this indicated that the activation of an ion channel on the 
Figure 2.2: Antimycin A evokes Ca2+ responses in a portion of nociceptors. Cytosolic Ca2+ 
fluxes averaged across all neurons, and in neuronal subpopulations as defined by nociceptive 
status and antimycin A responses as time course (A) and bar graph (B) which also contains 
buffered calcium and calcium blocking responses (all neurons). * denotes p < .05 versus all 
neurons. % denotes p < .05 versus nociceptive neurons. # denotes p < .05 versus all 
responding nociceptors. @ denotes difference vs non-responding nociceptors and non-
nociceptors. 
Figure 2.3:  TRPM7 inhibition 
with NS8593 has no effect on 
Ca2+ fluxes in non-nociceptive 
neurons. 
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plasma membrane was responsible these Ca2+ fluxes.  We further investigated this hypothesis by 
inhibiting TRPM7(Wu et al., 2010a), a Ca2+ permeable ion channel which is expressed in all 
sensory neurons, activated by H2O2(Yoshida et al., 2006), and blocked by Ruthenium Red and 
Gd3+(Numata et al., 2007).  However, inhibition of TRPM7 using NS8593(Chubanov et al., 2012) 
failed to diminish Ca2+ fluxes (p > .05) (Fig. 2.3). 
   
Relative contributions of TRPA1 and TRPV1 
Due to the heterogeneity of responses and difficulties posed by nociceptor classifications, 
we evaluated the relative contributions of TRPA1 and TRPV1 using 1) the Ca2+ flux magnitude 
across all neurons 2) the portion of neurons which responded and 3) the Ca2+ flux magnitude in 
responding neurons.  We isolated the contributions of TRPA1 and TRPV1 using both KO and 
inhibition to remove the influence of the other channel.  As such, to study the impact of TRPV1 
we used we used KO (TRPA1-/-) and inhibition (TRPA1inh: A967079) of TRPA1 and to study the 
impact of TRPA1 we used KO (TRPV1-/-) and inhibition of TRPV1 (TRPV1inh: iodoresiniferatoxin, 
I-RTX).  To eliminate the influence of both channels, we used dual KO/inhibition of both TRPA1 
and TRPV1 using three conditions: 1) TRPV1inh + TRPA1inh, 2) TRPV1inh + TRPA1-/- and 3) 
TRPV1-/- + TRPA1inh.  Using these experimental conditions, we were able to evaluate the relative 
contributions of TRPA1 and TRPV1 while controlling for the interactions between TRPA1 and 
TRPV1.  In both TRPV1 only (TRPA1-/- p<.05, TRPA1inh p<.05), and TRPA1 only (TRPV1-/- p<.05, 
TRPV1inh p<.05)(Fig. 2.4 A, B, D) conditions diminished Ca2+ flux (averaged across all neurons) 
which was further decreased in dual inhibition/KO conditions (p< .05 vs. VR1 CreRosa, TRPV1 
only, and TRPA1 only) (Fig. 2.4 C, D).  Interestingly, the percentage of responding neurons was 
diminished in TRPA1 only (TRPV1inh 17% p<.05, TRPV1-/- 13% p<.05) but not TRPV1 only 
(TRPA1-/- 38%, TRPA1inh 36%) conditions (Fig. 2.4 E) as compared to VR1 CreRosa (36%).  With 
eliminating of the influence of both TRPA1 and TRPV1 using dual KO/inhibition, fewer than 5% 
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of neurons responded (p<.05 vs VR1 CreRosa, TRPA1 only and TRPV1 only) (Fig. 2.4 E).  As so 
few neurons responded, these conditions were eliminated from further analyses of the Ca2+ flux 
in responding nociceptors. In the responding neurons, there was a diminished Ca2+ flux in TRPV1 
only (p <.05, TRPA1-/- and TRPA1inh) but not TRPA1 only (p>.05, TRPV1-/- and TRPV1inh) 
conditions (Fig. 2.4 F).   
 
 
Due to the impact of TRPA1 and TRPV1 on both the percentage on neurons responding 
and the Ca2+ flux magnitude, we depicted this relationship using density histograms. (Fig. 2.5).  It 
must be noted that although we used the VR1 CreRosa mouse model for all wild type conditions, 
we used wild type mice for the WT + IRTX condition.  Therefore, classifications in WT + I-RTX 
Figure 2.4: Antimycin A evoked Ca2+ fluxes (all neurons) are decreased KO and inhibition 
of TRPA1 or TRPV1 and further decreased with dual KO/inhibition. Ca2+ fluxes are 
diminished with (A)TRPA1-/-, TRPA1inh (B)TRPV1, TRPV1 and further decreased with 
(C)TRPA1inh + TRPV1inh, TRPA1-/- + TRPV1inh and TRPA1inh + TRPV1-/-. Bar graphs depicting 
mean +/- SEM (D)Ca2+ flux, (E)percentage of responding neurons, and (F)Ca2+ flux in 
responding neurons. * denotes difference from wild type (p < .05), # denotes difference from 
single KO/inhibition of TRPA1 or TRPV1 (p < .05). 
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neurons relied on functional responses to AITC and capsaicin.  Overall, in wild type neurons a 
large portion of nociceptors exhibit a large Ca2+ flux while the non-responding nociceptors exhibit 
a response similar to that of non-nociceptive neurons (Fig. 2.5 A).  However, in dual inhibition/KO 
conditions with neither TRPA1 nor TRPV1 is available, responses are largely abolished (Fig. 2.5 
B-D).  In studies of the contribution of TRPV1 (TRPA1-/- and TRPA1inh), there is a decreased 
overall Ca2+ flux attributed to the decreased response in responding nociceptors as there was no 
change in the percent of responding neurons.  (Fig. 2.5 E-F, Fig 2.4 E-F).  The opposite was true 
in studies of the contribution of TRPA1 (TRPV1-/- and TRPV1inh), as the Ca2+ flux in responding 
neurons was unchanged while there was a decrease in the percent of responding neurons (Fig 
2.2 E-F, Fig 2.4 G-H). 
 
Figure 2.5: Density histograms for antimycin A evoked cytosolic Ca2+ fluxes in (A) wild 
type, (B)TRPA1inh + TRPV1inh, (C)TRPA1-/- + TRPV1inh, (D) TRPA1inh + TRPV1-/-, (E)TRPA1inh, 
(F)TRPA1-/-, (G)TRPV1inh, and (H)TRPV1-/- in non-nociceptive, responding nociceptive and 
non-responding nociceptive neurons. 
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DISCUSSION 
Here, we characterized the VR1 CreRosa mouse model which expresses td Tomato in all 
cells which have ever expressed TRPV1 (including those that no longer express TRPV1).  We 
found that with this model, 82% of vagal neurons were classified as nociceptive which is in line 
with current knowledge indicating that 77% of vagal neurons respond to TRPA1 and/or TRPV1 
agonists(Taylor-Clark et al., 2007).  Using our classification system (see common methods), only 
4% of nociceptors did not express td Tomato yet responded to AITC or capsaicin.  This is largely 
due to TRPA1 expression in non-TRPV1 lineage neurons as not all TRPA1 expressing neurons 
express TRPV1.  It has been previously demonstrated that TRPA1 is expressed in approximately 
9% of neurons which do not express TRPV1(Taylor-Clark et al., 2008a).  However, we did observe 
a Ca2+ flux during treatment with capsaicin in two of these neurons.  This could be due to either 
the recent expression of TRPV1 in the mouse prior to euthanasia or expressional changes which 
occur during cell culture as TRPV1 and TRPA1 expression is increased by growth 
factors(Diogenes et al., 2007; Xue et al., 2007) present in the fetal bovine serum (FBS) used to 
supplement the media.  Although FBS must be used for neuronal survival, its effects on protein 
expression are minimized by using neurons within 24 hours of isolation.  Additionally, due to the 
low number of neurons which responded to capsaicin, this is unlikely to affect nociceptor 
classification or experimental results. 
Confirming our lab’s prior work, antimycin A evoked a large Ca2+ flux which was isolated 
to nociceptive neurons most of which express TRPA1 and/or TRPV1.  However, while large-scale 
Ca2+ fluxes were isolated to nociceptive neurons, there was a much smaller Ca2+ flux observed in 
but non-nociceptive neurons and non-responding nociceptors.  This could be due to either 
extracellular or intracellular calcium sources.  As antimycin A evokes mitochondrial depolarization 
and Ca2+ release, the release of mitochondrial Ca2+ stores could explain this flux.  However, this 
could be due to activation of a Ca2+ permeable plasma membrane ion channel.  We investigated 
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these possibilities by preventing cellular Ca2+ entry using channel blockers (Gd3+ + Ruthenium 
red) and buffering the extracellular Ca2+ concentration to match the intercellular Ca2+ 
concentration.  As these methods blocked these Ca2+ fluxes, this suggests the activation of a Ca2+ 
permeable plasma membrane ion channel.  We identified TRPM7 as a possible contributor to this 
response.  However, inhibiting TRPM7 failed to diminish this Ca2+ flux.  Although it is possible that 
buffering extracellular Ca2+ and blocking cellular Ca2+ entry alters Ca2+ homeostasis in such a way 
that Antimycin A is incapable of triggering calcium release, it is more likely that this Ca2+ flux is 
due to the activation of an unknown plasma membrane ion channel.   
Despite these small-scale Ca2+ fluxes in all neurons, it is evident that either TRPA1 or 
TRPV1 are required for the larger-scale Ca2+ fluxes observed in a portion (60% of nociceptors, 
36% of all neurons) of nociceptive neurons.  This is demonstrated by the decreased Ca2+ fluxes 
observed with inhibition and KO of TRPA1 or TRPV1 and the abolishment Ca2+ flux observe with 
in dual KO/inhibition of TRPA1 and TRPV1.    Interestingly, TRPA1 and TRPV1 affected Ca2+ 
fluxes in different ways.  While TRPV1 KO and inhibition largely affected the percentage of 
responding neurons (no effect on Ca2+ flux magnitude in responding neurons), TRPA1 KO and 
inhibition largely affected the magnitude of Ca2+ fluxes in responding neurons (no effect on 
percentage of neurons responding).   These relationships between the percentage of responding 
neurons and magnitude of Ca2+ fluxes are most easily visualized in the density histograms. 
Although TRPA1 is expressed in a much lower percentage of vagal neurons (37% of neurons) in 
comparison to TRPV1 (66% of neurons)(Nassenstein et al., 2008; Nassenstein et al., 2010), the 
impact of this on the percentage of neurons which responded with TRPV1 inhibition and KO 
conditions is unclear.  Unfortunately, studying the influence of expressional differences in 
antimycin A evoked Ca2+ fluxes is complicated by the long times required for calcium responses 
to return to baseline, possible desensitization of TRPA1 following antimycin A treatment which 
hiders identification of TRPA1 expressing neurons.  Furthermore, there is no mouse model 
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equivalent to VR1 CreRosa for TRPA1 that can facilitate identification of TRPA1 expressing 
neurons.   
One of the most interesting findings is that only a portion of nociceptors responded during 
antimycin A treatment.  Using our dual KO/inhibition conditions we confirmed that the large-scale 
Ca2+ fluxes were indeed a result of TRPA1 and TRPV1 activation.  Interestingly, many neurons 
expressing TRPA1 and/or TRPV1, many did not respond to antimycin A treatment.   The reason 
underlying these differential responses (response vs non-response) is unknown.  However, these 
differential responses could be due to the heterogeneous nature of vagal neurons, baseline 
cellular redox state, mitochondrial metabolic status or other cellular signaling status.   In the next 
chapter we investigate aspects of mitochondrial function including mitochondrial polarization and 
ROS production on channel activation to provide insight into the relationship between 
mitochondrial function and the activation of TRPA1 and TRPV1.   
 
UNIQUE METHODS 
No unique methods used. 
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CHAPTER 3 
Mitochondrial modulation-induced activation of vagal sensory neuronal subsets by 
antimycin A, but not CCCP or rotenone, correlates with mitochondrial superoxide 
production1 
 
INTRODUCTION 
Inflammation, infection, physical damage and exogenous irritants are capable of 
significant nociceptor activation. As such, excessive activation of this sensory subpopulation 
contributes to a wide-range of disease states including chronic pain, irritable bowel disease, 
colitis, arthritis and asthma(Marchand et al., 2005; McMahon et al., 2015). It has been shown that 
nociceptive neurons, many of which express TRPA1 and/or TRPV1 are important to the 
development of sensory nerve hyperexcitability in allergic asthma(Buckley and Nijkamp, 1994; 
Trankner et al., 2014).  Currently, the effects of inflammatory states on sensory nerve activity are 
not fully understood.  One potential way in which inflammation may cause nociceptor activation 
is by inducing the dysfunction of mitochondria, which are densely packed within sensory nerve 
terminals(Hung et al., 1973; von During and Andres, 1988). Mitochondrial dysfunction 
encompasses events including morphology changes, ROS production, mitochondrial 
depolarization and calcium release. While catastrophic mitochondrial dysfunction induces 
apoptosis, mitochondrial dysfunction also initiates signaling events involved in cellular stress 
responses. Chronic inflammation induces changes in mitochondrial morphology associated with 
                                               
1 This study has been previously published in PLoS One Stanford, K.R., and T.E. Taylor-Clark. 2018. 
Mitochondrial modulation-induced activation of vagal sensory neuronal subsets by antimycin A, but not 
CCCP or rotenone, correlates with mitochondrial superoxide production. PLoS One. 13:e0197106. and is 
included with permission under the Creative Commons Attribution (CC BY) license. 
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dysfunction(Mabalirajan et al., 2008), and there are reports of an increased rate of mitochondrial 
DNA mutations and altered activity of ROS scavengers such as glutathione and superoxide 
dismutase in inflammatory states(Raby et al., 2007; López-Armada et al., 2013; Van Tilburg et 
al., 2014). Inflammatory signaling has been shown to directly inhibit complexes I, II, and IV of the 
mitochondrial electron transport chain (mETC), resulting in ROS production and mitochondrial 
depolarization(Stadler et al., 1992; Colell et al., 1997; Zell et al., 1997; Lopez-Armada et al., 2006).  
However, the direct impact of this on sensory nerve activity is largely unknown.   
We have previously demonstrated that mitochondrial dysfunction induced by antimycin A, 
an mETC complex III inhibitor, activates vagal sensory neurons and bronchopulmonary C-fibers 
via the gating of TRPA1 and TRPV1(Nesuashvili et al., 2013). Inhibition of complex III by 
antimycin A induces ROS production and mitochondrial depolarization(Chinopoulos et al., 1999; 
Starkov and Fiskum, 2001), but the role of these events in mitochondrial dysfunction-induced 
neuronal activation has not been established. Here we investigated the influence of mitochondrial 
dysfunction on the activation of vagal sensory neurons using three mitochondrial agents: 
antimycin A, carbonyl cyanide m-chlorophenyl hydrazone (CCCP, mitochondrial uncoupling 
agent), and rotenone (mETC complex I inhibitor). Using live cell co-imaging, we simultaneously 
monitored cytosolic calcium (as a surrogate for neuronal activation) and either mitochondrial 
superoxide production or changes in mitochondrial polarization. We found that the three agents 
activated (i.e. caused significant calcium fluxes) only a subset of TRPA1 and/or TRPV1 
expressing (A1/V1+) neurons, yet there was no difference in mitochondrial superoxide production 
or mitochondrial depolarization between ‘responding’ and ‘non-responding’ A1/V1+ neurons. 
Nevertheless, we observed a significant correlation between antimycin A-induced calcium 
responses and mitochondrial superoxide production in wild-type ‘responding’ A1/V1+ neurons, 
which was eliminated in TRPA1-/- neurons, but not TRPV1-/- neurons. CCCP-induced calcium 
responses did not correlate with either superoxide production or mitochondrial depolarization. 
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Rotenone-induced calcium responses correlated with mitochondrial depolarization but not 
superoxide production. Our data are consistent with the hypothesis that mitochondrial dysfunction 
causes the activation of a subset of A1/V1+ neurons via ROS-dependent and ROS-independent 
mechanisms. 
 
RESULTS 
Correlation between mitochondrial O2- production and Ca2+ responses 
Endogenous mediators modulate mitochondria at several different sites, thus we 
investigated neuronal responses to three mitochondrial agents: antimycin A (Complex III 
inhibitor), CCCP (uncoupling agent) and rotenone (Complex I inhibitor). We evaluated the 
contribution of mitochondrial superoxide production to neuronal activation by simultaneously 
measuring mitochondrial superoxide (MitoSOX Red) and cytosolic calcium (Fura-2AM) in 
dissociated vagal neurons using live cell co-imaging in response to antimycin A (10μM, n = 282 
from 8 experiments), CCCP (10μM, n = 266 from 10 experiments), rotenone (5μM, n = 177 from 
6 experiments) or DMSO vehicle (0.1%, n = 122 from 7 experiments). Approximately 60% of vagal 
sensory neurons were defined as A1/V1+, i.e. they subsequently responded to a combined 
treatment of 1μM capsaicin and 100μM AITC. All three agents produced a substantially larger 
increase in [Ca2+]i in the A1/V1+ neuronal population compared to the A1-V1- population 
(p<0.05)(Fig. 3.1 A, B, C, I). Indeed the vehicle also produced a minor, yet significant, increase in 
[Ca2+]i in A1/V1+ neurons versus A1-V1- neurons (p<0.05)(Fig. 3.1D, I). Nevertheless the 
increase in [Ca2+]i in A1/V1+ neurons in response to antimycin A, CCCP and rotenone was 
significantly greater than that evoked by vehicle (p<0.05)(Fig. 3.1 I). This data is consistent with 
our previous studies demonstrating antimycin A evoked calcium transients that were dependent 
on extracellular calcium and TRPA1 and TRPV1(Nesuashvili et al., 2013). Only CCCP evoked an 
increase in [Ca2+]i in A1-V1- neurons that was greater than vehicle (p<0.05)(Fig. 3.1 B, D I). 
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Figure 3.1: [Ca2+]i and mitochondrial superoxide responses of vagal neurons to 
antimycin A, CCCP, rotenone and vehicle. Mean +/- SEM [Ca2+]i responses (A–D) and 
mitochondrial superoxide (MitoSOX) responses (E–H) in A1/V1+ (black line) and A1-V1- (grey 
line) neurons treated with 10μM antimycin A (A, E), 10μMCCCP (B, F), 5μM rotenone (C, G) 
and 0.1% DMSO (D, H). Each panel includes representative Fura-2AM/MitoSOX image of an 
A1/V1+ neuron before and after treatment with the mitochondrial agent. A1/V1+ neurons are 
defined by increase in [Ca2+]i following AITC/Caps treatment. (I) Mean +/- SEM maximal [Ca2+]i 
response ofA1/V1+ and A1-V1- neurons. (J) Mean +/- SEM maximal mitochondrial superoxide 
response ofA1/V1+ and A1-V1- neurons (insert, mean +/- SEM maximal mitochondrial 
superoxide response of all neurons). (K) Percentage of neurons defined as ‘responding’ A1/V1+ 
neurons, ‘non-responding’ A1/V1+ neurons and A1-V1- neurons. (L) Mean +/- SEM maximal 
[Ca2+]i response of responding’ A1/V1+ neurons, ‘non-responding’ A1/V1+ neurons and A1-V1- 
neurons. (M) Mean +/- SEM maximal mitochondrial superoxide response of ‘responding’ 
A1/V1+ neurons, ‘non-responding’ A1/V1+ neurons and A1-V1- neurons. * denotes significant 
difference compared to vehicle (p<0.05), $ denotes significant difference between A1/V1+ and 
A1-V1- groups (p<0.05), # denotes significant difference between ‘responding’ and ‘non-
responding’ A1/V1+ groups (p<0.05), ns denotes non-significance (p>0.05). 
 
MitoSOX measurements in the dual imaging studies showed that antimycin A and CCCP 
evoked significant mitochondrial superoxide production compared to vehicle in A1/V1+ neurons, 
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A1-V1- neurons and the total neuronal population (p<0.05)(Fig. 3.1 E, F, H, J) (p<0.05). Despite 
the differences in calcium responses between A1/V1+ and A1-V1- populations, there was no 
differences in the magnitude of mitochondrial superoxide production in A1/V1+ and A1-V1- 
neurons evoked by either antimycin A or CCCP (p>0.05)(Fig. 3.1 E, F J). Rotenone failed to evoke 
significant mitochondrial superoxide production in either A1/V1+, A1-V1- or total populations 
compared to vehicle (Fig. 3.1 G, H, J). In general, rotenone had a minor inhibitory effect on the 
accumulation of MitoSOX fluorescence, which was more pronounced in the A1/V1+ population 
compared to the A1-V1- population (p<0.05)(Fig. 3.1 G, J). 
When we evaluated the calcium responses on a cell-by-cell basis we found that the 
mitochondrial agents only increased [Ca2+]i beyond that evoked in A1-V1- neurons in a proportion 
of A1/V1+ neurons (see methods for definition of the threshold): antimycin A: 96/167, CCCP: 
50/141, rotenone: 35/108 (Fig. 3.1 K). This ‘responding’ A1/V1+ population represents the A1/V1+ 
neurons ‘activated’ by the mitochondrial modulators and, consistent with this, the increase in 
[Ca2+]i evoked by antimycin A, CCCP and rotenone was significantly greater in the ‘responding’ 
A1/V1+ population than either the ‘non-responding’ A1/V1+ or A1-V1- populations (p<0.05)(Fig. 
3.1 L). CCCP-evoked increases in [Ca2+]i were marginally yet significantly greater in ‘non-
responding’ A1/V1+ compared to A1-V1- neurons (p<0.05), but this was not the case for either 
antimycin A or rotenone (p>0.05)( Fig. 3.1 L). Importantly, there was no difference in mitochondrial 
superoxide production between ‘responding’ and ‘non-responding’ A1/V1+ neurons or A1-V1- 
neurons for any of the mitochondrial modulators (p>0.05)(Fig. 3.1 M). 
Scatterplot analysis of the calcium and MitoSOX responses (Fig. 3.2) showed that 
mitochondrial superoxide production in response to antimycin A and CCCP was highly variable in 
all neuronal populations (i.e. ‘responding’ A1/V1+, ‘non-responding’ A1/V1+, and A1-V1- groups). 
Overall, only 40% and 23% of neurons exhibited an increase in mitochondrial superoxide 
production following treatment with antimycin A and CCCP, respectively (compared to 1.6% for 
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vehicle, see methods for calculation). Antimycin A-evoked calcium responses correlated with 
mitochondrial superoxide production in the responding A1/V1+ population and in the total A1/V1+ 
population (p<0.05)(Fig. 3.2 A, Table 3.1). However, there was no correlation between calcium 
and MitoSOX responses for CCCP in any neuronal population (p>0.05)(Fig. 3.2 B, Table 3.1). 
Rotenone failed to evoke mitochondrial superoxide production in any neuronal population (0%) 
and as such there was no correlation between calcium and MitoSOX responses (p>0.05)(Fig. 3.2 
C, Table 3.1). 
 
 
 
 
 
Figure 3.2: Mitochondrial superoxide responses correlates with [Ca2+]i responses for 
antimycin A, but not CCCP or rotenone. Co-imaging of [Ca2+]i and superoxide in neurons 
treated with 10μM antimycin A (A), 10μM CCCP (B), 5μM rotenone (C) and 0.1% DMSO (D). 
Trendlines depict the correlation across all A1/V1+ neurons. Slope and significance of each 
trendline is presented in Table 3.1. 
Table 3.1: Trendlines for the correlation of [Ca2+]i  and mitochondrial superoxide in 
subsets of vagal A1/V1+ neurons after treatment with antimycin, CCCP and rotenone.  
* denotes p < 0.05 
 
 Responding  
A1/V1+ 
Non-responding  
A1/V1+ 
A1/V1+ 
 Slope p Sig Slope p Sig Slope p Sig 
Wild Type          
Antimycin A 0.48 3.03e-8 * -0.04 0.99  0.31 2.68e-6 * 
CCCP 0.27 0.06  -0.03 0.72  0.13 0.15  
Rotenone 0.41 0.31  -0.02 0.71  -0.06 0.51  
Vehicle -0.15 0.69  0.10 0.13  0.00 0.51  
TRPA1 -/-          
Antimycin A 0.04 0.23  -0.01 0.84  0.05 0.10  
TRPV1 -/-          
Antimycin A 0.42 0.03 * -0.01 0.95  -0.04 0.74  
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We have shown previously that antimycin A-induced calcium responses in nociceptive 
neurons were largely dependent on calcium influx through the cation channels TRPA1 and 
TRPV1(Nesuashvili et al., 2013). Here, we found in a separate series of Fura-2AM studies in 
vagal neurons (n = 381) that increases in [Ca2+]i in A1/V1+ neurons in response mitochondrial 
modulation were largely dependent on extracellular calcium (Fig. 3.3). There were no differences 
in calcium responses in A1/V1+ and A1-V1- neurons in response to antimycin A (10μM), CCCP 
(10μM), rotenone (5μM) or DMSO vehicle (0.1%) when extracellular calcium was buffered to 
75nM with EGTA (p>0.05). Only CCCP evoked significantly greater responses in vagal neurons 
compared to vehicle (p<0.05), suggesting that some of the CCCP-evoked calcium transient (in  
both A1/V1+ and A1-V1- neurons) was dependent on intracellular stores. 
 
TRPA1 is directly activated by ROS(Andersson et al., 2008; Sawada et al., 2008; 
Takahashi et al., 2008), whereas there is little evidence that TRPV1 is activated by 
ROS(Andersson et al., 2008; Sawada et al., 2008; Ogawa et al., 2016). We therefore investigated 
antimycin A-evoked Fura-2AM calcium and MitoSOX responses in vagal neurons from TRPA1-/- 
and TRPV1-/- mice (n = 258 from 9 experiments and n = 201 from 10 experiments, respectively). 
 
Figure 3.3: [Ca2+]i responses of vagal neurons to antimycin A, CCCP, rotenone and 
vehicle in the nominal absence of extracellular calcium. (A) Mean +/- SEM [Ca2+]i responses 
in A1/V1+ (black line) and A1-V1- (grey line) neurons treated with 10μM antimycin A, 10μM 
CCCP, 5μM rotenone and 0.1% DMSO. Blocked line denotes stimulus application. A1/V1+ 
neurons are defined by increase in [Ca2+]i following AITC/Caps treatment in the presence of 
2.5mM CaCl2 (data not shown). (B) Mean +/- SEM maximal [Ca2+]i response of A1/V1+ and A1-
V1- neurons. * denotes significant difference compared to vehicle (p<0.05), $ denotes significant 
difference between A1/V1+ and A1-V1- groups (p<0.05). 
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[Ca2+]i and mitochondrial superoxide production correlated in ‘responding’ trpv1-/- A1+ neurons 
(p<0.05)(Fig. 3.4 A, Table 3.1) but not in ‘responding’ trpa1-/- V1+ neurons (p>0.05)(Fig. 3.4 B, 
Table 3.1). Similar to the wild-type A1/V1+ neurons, mitochondrial modulation with antimycin A 
failed to evoke calcium responses in all trpv1-/- A1+ neurons, suggesting the possibility that some 
neurons expressing the TRPA1 channel were insensitive to ROS.  Sequential exposure of vagal 
neurons from TRPV1-/- mice (n = 202 from 7 experiments) to antimycin A (10μM), H2O2 (300μM) 
and then AITC (100μM), showed that a significant proportion of antimycin-insensitive, A1+ 
neurons did indeed respond to the H2O2 with an increase in calcium (Fig. 3.4 C, D). This data 
confirms the sensitivity of TRPA1 channels in these neurons to exogenously applied ROS H2O2. 
 
 
 
Correlation between mitochondrial depolarization and Ca2+ responses 
Given that our data suggests that mitochondrial superoxide is not the only determinant of 
mitochondrial modulation-induced A1/V1+ neuronal activation, we next investigated mitochondrial 
depolarization–another hallmark of mitochondrial dysfunction. We performed live cell co-imaging 
of cytosolic Ca2+ (Fura-2AM) and mitochondrial polarization (JC-1) during treatment with 
antimycin A (10μM, n = 90 from 6 experiments), CCCP (10μM, n = 210 from 10 experiments), 
Figure 3.4: Antimycin A-induced [Ca2+]i responses correlates with mitochondrial 
superoxide responses in trpv1-/- A1+ neurons but not trpa1-/- V1+ neurons. Co-imaging of 
[Ca2+]i and superoxide in neurons treated with 10μM antimycin A in neurons from TRPV1-/- (A) 
and TRPA1-/- (B) mice. Trendlines depict the correlation across all A1/V1+ neurons. Slope and 
significance of each trendline is presented in Table 1. (C) Mean +/- SEM [Ca2+]i responses in 
neurons from TRPV1-/- mice treated with 10μM antimycin A, 300μM H2O2 and 100μM AITC. 
Neurons allocated to groups based upon sensitivity to the stimuli. A1+ defined by response to 
AITC. (D) Percentage of neurons from TRPV1-/- mice allocated to groups shown in C. 
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rotenone (5μM, n = 112 from 7 experiments) and DMSO vehicle (0.1%, n = 129 from 8 
experiments) (Fig. 3.5). 
 
Figure 3.5: [Ca2+]i and mitochondrial polarization responses of vagal neurons to 
antimycin A, CCCP, rotenone and vehicle. Mean +/- SEM [Ca2+]i responses (A–D) and 
mitochondrial polarization (JC-1) responses (E–H) in A1/V1+ (black line) and A1-V1- (grey line) 
neurons treated with 10μM antimycin A (A, E), 10μM CCCP (B, F), 5μM rotenone (C, G) and 
0.1% DMSO (D, H). Each panel includes representative Fura-2AM/JC-1 image of an A1/V1+ 
neuron before and after treatment with the mitochondrial agent. A1/V1+ neurons are defined 
by increase in [Ca2+]i following AITC/Caps treatment. (I) Mean +/- SEM maximal [Ca2+]i 
response of A1/V1+ and A1-V1- neurons. (J) Mean +/- SEM maximal mitochondrial 
depolarization of A1/V1+ and A1-V1- neurons (insert, mean +/- SEM maximal mitochondrial 
depolarization of all neurons). (K) Percentage of neurons defined as ‘responding’ A1/V1+, ‘non-
responding’ A1/V1+ and A1-V1-. (L) Mean +/- SEM maximal [Ca2+]i response of ‘responding’ 
A1/V1+, ‘non-responding’ A1/V1+ and A1-V1-. (M) Mean +/- SEM maximal mitochondrial 
depolarization of ‘responding’ A1/V1+, ‘nonresponding’ A1/V1+ and A1-V1-. * denotes 
significant difference compared to vehicle (p<0.05), $ denotes significant difference between 
A1/V1+ and A1-V1- groups (p<0.05), # denotes significant difference between ‘responding’ and 
‘non-responding’ A1/V1+ groups (p<0.05), ns denotes non-significance (p>0.05). 
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Again, approximately 60% of vagal sensory neurons were defined as A1/V1+, and all three 
mitochondrial agents evoked substantially larger increases in [Ca2+]i in the A1/V1+ neuronal 
population compared to the A1-V1- population (p<0.05)(Fig. 3.5 A, B, C, I), and these responses 
were significantly greater than those evoked by vehicle (p<0.05)(Fig. 3.5 D, I). Again, CCCP alone 
evoked an increase in [Ca2+]i in A1-V1- neurons that was greater than vehicle (p<0.05)(Fig. 3.5 
B, D, I). Antimycin A and CCCP both caused significant mitochondrial depolarization compared 
to vehicle (p<0.05) but there were no differences between A1/V1+ and A1-V1- populations 
(p>0.05)(Fig. 3.5 E, F, H, J). Mitochondrial depolarization occurred in 97% and 80% of neurons 
in response to antimycin A and CCCP, respectively (compared to 0.8% for vehicle). Although 
rotenone failed to evoke significant mitochondrial depolarization compared to vehicle in the total, 
A1/V1+ and A1-V1- populations overall (Fig. 3.5 G, J), rotenone did evoke mitochondrial 
depolarization in 38% of neurons (compared to 0.8% for vehicle). 
Analysis of individual neuronal responses showed again that the mitochondrial agents 
only increased [Ca2+]i beyond that evoked in A1-V1- neurons in a proportion of A1/V1+ neurons: 
antimycin A: 33/55, CCCP: 41/122, rotenone: 23/57 (Fig. 3.5 K). Indeed, the increase in [Ca2+]i 
evoked by antimycin A, CCCP and rotenone was significantly greater in the ‘responding’ A1/V1+ 
population than either the ‘non-responding’ A1/V1+ or A1-V1- populations (p<0.05)(Fig. 3.5 L).  
Notably, there were no differences in mitochondrial depolarization between ‘responding’ A1/V1+ 
and ‘non-responding’ A1/V1+ neurons for each of the agents (p>0.05)(Fig. 3.5 M). Using 
scatterplots of the cell-by-cell responses, we found there was no correlation of calcium responses 
evoked by either antimycin A or CCCP to mitochondrial depolarization in ‘responding’ A1/V1+ 
neurons (p>0.05)(Fig. 3.6 A, B, Table 3.2). Nevertheless, there was a minor, yet significant 
correlation of rotenone-induced calcium responses to mitochondrial depolarization in ‘responding’  
A1/V1+ neurons (p>0.05)(Fig. 3.6 C, Table 3.2), consistent with the finding that some neurons 
exhibited mitochondrial depolarization with rotenone. 
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Table 3.2: Trendlines for the correlation of [Ca2+]i  and mitochondrial depolarization in 
subsets of vagal A1/V1+ neurons after treatment with antimycin, CCCP and rotenone.  
* denotes p<0.05 
 
 Responding  
A1/V1+ 
Non-responding  
A1/V1+ 
A1/V1+ 
 Slope p Sig Slope p Sig Slope p Sig 
Wild Type          
Antimycin A 0.15 0.22  0.02 0.13  0.09 0.26  
CCCP -0.12 0.88  0.03 0.03 * -0.05 0.82  
Rotenone 2.08 0.03 * -0.12 0.87  0.71 0.09  
Vehicle -0.45 0.69  0.13 0.37  -0.48 0.81  
 
DISCUSSION 
Nociceptive activation is a hallmark of inflammation in multiple organs, resulting in 
debilitating symptoms (e.g. pain) and reflexes (e.g. vasodilation, edema, bronchospasm, 
etc.)(Tatar et al., 1988; Gold and Gebhart, 2010; Biringerova et al., 2013). While inflammatory 
signaling pathways involving TNFα, ceramides and neurotrophins inhibit complexes of the mETC 
and induce mitochondrial dysfunction (ROS production, depolarization, and Ca2+ release)(Stadler 
et al., 1992; Colell et al., 1997; Zell et al., 1997; Lopez-Armada et al., 2006), the mechanisms 
linking these factors to C-fiber activity are largely unknown. In a previous study, we demonstrated 
that inhibition of mETC complex III with antimycin A activated bronchopulmonary C-fibers via the 
 
Figure 3.6: Mitochondrial depolarization responses correlates with [Ca2+]i responses for 
rotenone, but not antimycin A or CCCP. Co-imaging of [Ca2+]i and mitochondrial polarization 
in neurons treated with 10μM antimycin A (A), 10μM CCCP (B), 5μM rotenone (C) and 0.1% 
DMSO (D). Trendlines depict the correlation across all A1/V1+ neurons. Slope and significance 
of each trendline is presented in Table 3.2. 
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activation of TRPA1 and TRPV1(Nesuashvili et al., 2013)–Ca2+-permeable cation channels 
selectively expressed on many nociceptive sensory neurons(Nassenstein et al., 2008; Taylor-
Clark et al., 2008b; Nesuashvili et al., 2013). However, the influence of specific aspects of 
mitochondrial function on TRPA1 and TRPV1 activation remains unknown. Here, we investigated 
the correlation of mitochondrial depolarization and superoxide production on calcium fluxes in 
dissociated vagal neurons following mitochondrial modulation. 
As inflammatory signaling inhibits the mETC at multiple sites, we performed these 
experiments using three mitochondrial agents: antimycin A (complex III inhibitor), rotenone 
(complex I inhibitor), and CCCP (mitochondrial uncoupling agent). Here, we found that all three 
agents caused robust increases in [Ca2+]i in the vagal A1/V1+ neuronal population. These data 
are consistent with our previous study that antimycin A evoked a selective increase in [Ca2+]i in 
A1/V1+ vagal neurons that was abolished by the removal of extracellular Ca2+ or by the genetic 
and pharmacological blockade of the nociceptive-specific ion channels TRPA1 and 
TRPV1(Nesuashvili et al., 2013). Given that TRPA1/TRPV1 were required for antimycin A-
induced bronchopulmonary C-fiber activation(Nesuashvili et al., 2013), it is likely that the 
mitochondrial agent-evoked increases in [Ca2+]i in A1/V1+ neurons observed in this study 
represents preferential activation of A1/V1+ neurons. However, not all A1/V1+ neurons 
‘responded’ to mitochondrial modulation: approximately 60%, 35% and 35% of A1/V1+ neurons 
exhibited an increase in [Ca2+]i to antimycin A, CCCP and rotenone, respectively. In general, 
antimycin A and CCCP evoked greater increases in [Ca2+]i in ‘responding’ A1/V1+ neurons than 
rotenone. There was no correlation between responses in individual A1/V1+ neurons and their 
proximity to other neurons (data not shown), suggesting that calcium responses in each neuron 
was independent of the effects of mitochondrial modulation in other neurons. 
Mitochondrial modulation can evoke ROS production, most notably at complexes I and III, 
when electrons leak and incompletely oxidize O2 resulting in O2•- (superoxide) formation(Han et 
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al., 2001; Chen et al., 2003; Turrens, 2003; Lai et al., 2005). Superoxide is membrane 
impermeable and highly reactive, thus is capable of damaging DNA, proteins and lipids. In cells, 
superoxide dismutase rapidly converts superoxide to H2O2 which is membrane permeable but 
less reactive(Stowe and Camara, 2009). Here, we found that antimycin A increased mitochondrial 
superoxide production acutely in both A1/V1+ and A1-V1- neurons. Furthermore, there was no 
difference in the mitochondrial superoxide production evoked by antimycin A between the 
‘responding’ A1/V1+ and ‘non-responding’ neurons. Nevertheless, there was a significant 
correlation between antimycin A-evoked mitochondrial superoxide production and the magnitude 
of calcium responses in ‘responding’ A1/V1+ neurons. Our interpretation of these data is that 
mitochondrial superoxide produced by antimycin A can lead to A1/V1+ neuronal activation, but 
this is dependent on another unknown factor that is not present in all A1/V1+ neurons. It should 
be noted that only 40% of all neurons exhibited increased superoxide production in response to 
antimycin A, raising the possibility that some neurons are insensitive to this mitochondrial 
modulating agent. However, this seems unlikely given the observation that 97% of neurons 
exhibited antimycin A-induced mitochondrial depolarization. 
Both superoxide and H2O2 are potent activators of TRPA1(Sawada et al., 2008; Takahashi 
et al., 2008). Here, we found a significant correlation between antimycin A-evoked mitochondrial 
superoxide production and the magnitude of calcium responses in ‘responding’ trpv1-/- A1+ 
neurons, whose responses are presumed to be mediated by ROS-sensitive TRPA1 
alone(Nesuashvili et al., 2013). Nevertheless, some trpv1-/- A1+ neurons failed to be activated 
despite substantial superoxide production, thus again suggesting that some other unknown factor 
is required for mitochondrial ROS-mediated TRPA1 activation. Separate studies confirmed that 
many non-responding trpv1-/- A1+ neurons were activated by exogenously-applied H2O2. 
Importantly, there was no correlation between antimycin A-evoked mitochondrial superoxide 
production and the magnitude of calcium responses in ‘responding’ trpa1-/- V1+ neurons, whose 
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responses are likely mediated by TRPV1(Nesuashvili et al., 2013). There is little evidence to 
suggest that TRPV1 is a major target of ROS and oxidative stress: TRPV1 is not activated by 
physiological concentrations of H2O2(Sawada et al., 2008; Ogawa et al., 2016) or most 
electrophilic products of lipid peroxidation(Gouin et al., 2017), although it is activated by high 
concentrations of 4-oxononenal(Taylor-Clark et al., 2008a). Instead, TRPV1 is activated by PIP2 
hydrolysis, GPCR signaling and arachidonic acid metabolites(Prescott and Julius, 2003; 
Watanabe et al., 2003; Wen et al., 2012; Gouin et al., 2017). Our data further suggests that 
TRPV1-mediated activation by antimycin A is not downstream of superoxide production. 
Like antimycin A, CCCP evoked significant mitochondrial superoxide production in all 
neuronal populations, consistent with previous reports in isolated rat brain 
mitochondria(Votyakova and Reynolds, 2001), although other studies indicate that uncoupling 
agents such as CCCP do not increase ROS production(Sipos et al., 2003; Suski et al., 2012). 
However, there was no correlation between CCCP-induced mitochondrial superoxide production 
and the magnitude of calcium responses in ‘responding’ A1/V1+ neurons. Approximately 80% of 
neurons exhibited mitochondrial depolarization to CCCP, but there were no significant differences 
between the mitochondrial depolarization in ‘responding’ A1/V1+ and ‘non-responding’ neurons 
and there was no correlation between mitochondrial depolarization and the magnitude of calcium 
responses in ‘responding’ A1/V1+ neurons. We therefore conclude that factors other than 
mitochondrial superoxide production determine the CCCP-induced activation of A1/V1+ neurons 
and that mitochondrial depolarization alone is unable to account for these responses. 
Rotenone failed to cause mitochondrial superoxide production in any neuronal population. 
Indeed, rotenone decreased baseline mitochondrial ROS production in A1/V1+ neurons. Previous 
studies have shown that rotenone can increase or decrease ROS production depending on 
metabolism of complex I versus complex II substrates(Chen et al., 2003; Hoffman and Brookes, 
2009). Despite the lack of superoxide production, rotenone evoked an increase in [Ca2+]i in 
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approximately 35% of A1/V1+ neurons in this study. Although rotenone caused mitochondrial 
depolarization in approximately 38% of all vagal neurons, there were no significant differences 
between the mitochondrial depolarization in ‘responding’ A1/V1+ and ‘non-responding’ neurons. 
Nevertheless, there was a significant correlation between rotenone-evoked mitochondrial 
depolarization and the magnitude of calcium responses in ‘responding’ A1/V1+ neurons. This 
suggests that mitochondrial depolarization alone can lead to A1/V1+ neuronal activation, but 
again this is dependent on another unknown factor that is not present in all A1/V1+ neurons. 
Our data indicates that mitochondrial modulators (in particular antimycin A and CCCP) 
evoke mitochondrial superoxide production in a limited percentage of neurons despite the evident 
mitochondrial depolarization in the majority of neurons. The present study used quantitative 
measurements of mitochondrial superoxide using MitoSOX, which is neither ratiometric nor 
reversible, making it possibly susceptible, despite our efforts to normalize the data, to variations 
in loading and baseline redox state. MitoSOX is targeted to the mitochondrial matrix, thus it is 
possible that some of the superoxide produced from complex I and III may evade MitoSOX 
detection following its release into the intermembrane space(Han et al., 2001; St-Pierre et al., 
2002; Muller et al., 2004). ROS produced within sensory neurons has 3 potential fates: reacting 
with signaling pathways, with endogenous antioxidant systems (e.g. glutathione) or with the ROS-
sensitive dye. As such, the quantification of ROS production may be susceptible to significant 
error on a cell-by-cell basis. Nevertheless, even a qualitative analysis suggests that (A) 
mitochondrial modulation does not evoke significant calcium responses in all A1/V1+ neurons and 
(B) significant ROS production does not necessarily evoke calcium responses in A1/V1+ neurons. 
This suggests that factors in addition to superoxide determine the TRPA1- and TRPV1-mediated 
calcium responses in A1/V1+ neurons. The identity of these factors is presently unknown, but it 
is possible that these either involve the activity of antioxidant systems or the spatial/temporal 
arrangement of mitochondria, TRP channels and signaling molecules. Our rotenone studies 
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suggest that mitochondrial depolarization is able to contribute, but experiments with CCCP (and 
antimycin A) indicate that mitochondrial depolarization is not guaranteed to result in significant 
calcium responses in A1/V1+ neurons. How mitochondrial depolarization could contribute to 
A1/V1+ neuronal activation is not yet known. Mitochondrial depolarization causes calcium efflux 
from the matrix, and calcium is a regulator of multiple pathways such as phospholipases and 
protein kinases(Cuchillo-Ibáñez et al., 2004; Rizzuto et al., 2012) that can alter TRP channel 
activity(Bandell et al., 2004; Mandadi et al., 2006a; Cao et al., 2013; Gouin et al., 2017). 
Unlike antimycin A and rotenone, CCCP evoked a significant increase in [Ca2+]i in A1-V1- 
neurons, although these were much smaller than those in A1/V1+ neurons. As such, the threshold 
for determining the calcium ‘responsiveness’ of a particular neurons is greater for CCCP 
treatments. A1-V1- neurons do not express TRPA1 or TRPV1. Thus, the source of the CCCP-
evoked calcium responses in A1-V1- is presently unknown. It is possible that calcium release 
from the mitochondrial matrix after robust mitochondrial depolarization contributes to these 
calcium transients(Shishkin et al., 2002), and this is consistent with (A) the significant calcium 
responses with CCCP in the nominal absence of extracellular calcium and (B) the significant 
correlation between CCCP-evoked mitochondrial depolarization and the magnitude of calcium 
responses in A1-V1- neurons (slope 0.035, p<0.05, data not shown). 
The present study has investigated the correlation between mitochondrial 
ROS/depolarization and calcium transients evoked by mitochondrial modulators in vagal neurons. 
Our previous study identified the critical role of TRPA1 and TRPV1 in antimycin A-induced calcium 
responses and bronchopulmonary C-fiber activation(Nesuashvili et al., 2013). Although the 
specific role of TRPA1 and TRPV1 has not been extensively investigated in the present study, 
our data is consistent with TRPA1 and TRPV1 mediating the mitochondrial modulator-evoked 
calcium responses. It is important to note, however, that TRP channel sensitivity itself is not static 
and that multiple intracellular pathways, including oxidative stress, can promote either 
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sensitization or desensitization of TRPA1 and TRPV1 channels(Susankova et al., 2006; Wang et 
al., 2008; Rohacs, 2015; Meents et al., 2017). Furthermore, TRPA1 and TRPV1 have been 
reported to functionally modulate each other’s sensitivity(Spahn et al., 2014; Weng et al., 2015). 
Although not addressed here, it is possible that mitochondrial modulation may impact TRP 
function beyond channel activation. 
In summary, we have shown that mitochondrial modulation by antimycin A-induced 
TRPA1-mediated calcium responses in vagal A1/V1+ neurons correlates with mitochondrial 
superoxide production, but that other factors including mitochondrial depolarization may 
contribute to A1/V1+ neuronal calcium responses via TRPV1 and downstream of complex I 
inhibition and mitochondrial uncoupling. It should be emphasized that the conclusions here are 
based upon correlations, which do not necessarily imply causation. Thus, we note that these 
studies do not show a conclusive role of superoxide production in the A1/V1+ neuronal Ca2+ 
responses by mitochondrial modulators. Furthermore, we have focused our present study on the 
cell body of dissociated vagal neurons and it is possible that mechanisms linking mitochondrial 
superoxide production and depolarization with TRP channel activation may be different within 
sensory terminals in vivo. More studies are needed to fully understand the events linking 
mitochondrial dysfunction and nociceptor activation. 
 
UNIQUE METHODS 
Imaging analysis (MitoSOX and JC-1) 
Images were analyzed using Nikon Elements (Nikon, Melville, NY). Each individual neuron 
was analyzed separately using a region of interest (ROI) that encompassed the entire intracellular 
region. If required, ROIs were tracked over time to account for any cellular movement. For each 
imaging method (Fura-2AM, MitoSOX, and JC-1), ROIs with an unstable baseline, noisy baseline 
or insufficient loading were eliminated from the analysis. Neurons that possessed an initial JC-1 
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red/green (525nm/610nm) ratio under 0.5 were eliminated as this indicated mitochondrial 
depolarization prior to the start of the experiment. For statistical analyses, we analyzed the 
maximal Fura-2AM, JC-1 and MitoSOX responses during the three-minute drug treatment (see 
below for calculations).  For specifics regarding FURA-2AM imaging analysis and quantification 
of response, see common methods. 
Mitochondrial superoxide production was analyzed using MitoSOX fluorescence (F, 
excitation at 535nm). Given that the reaction of superoxide with MitoSOX red is irreversible and 
that baseline physiologic ROS production by mitochondria will vary between individual neurons, 
we have chosen to correct for the slope in the time series studies using F1(adjusted) = F1 - (S0 * t), 
where F1 is the raw fluorescence at a given timepoint (in arbitrary fluorescent units), S0 is the 
slope of the baseline (arbitrary fluorescent units/s) and t is time of the F1 measurement (in 
seconds). As MitoSOX loading varies between individual neurons, we have normalized the slope 
corrected data: F1(adjusted)/F0(adjusted), where F1(adjusted) is the slope corrected fluorescence at a given 
timepoint and F0(adjusted) is the average of the slope corrected baseline. In order to determine the 
percentage of neurons that exhibited meaningful mitochondrial superoxide production compared 
to vehicle, we calculated the percentage of neurons whose individual maximal F1(adjusted)/F0(adjusted) 
was greater than the average maximal F1(adjusted)/F0(adjusted) for vehicle treatment + 3 * standard 
deviation of the maximal F1(adjusted)/F0(adjusted) for vehicle treatment. 
Mitochondrial polarization was determined using JC-1 fluorescence at both the green 
(525nm, which measures the monomeric form of JC-1) and red (610nm, which measures the 
aggregated form of JC-1) emission wavelengths. JC-1 accumulates in negatively charged 
mitochondria and forms ‘red’ aggregates. Upon mitochondrial depolarization, JC-1 disperses into 
the cytosol as the ‘green’ monomeric form. As mentioned above, the 525nm/610nm ratio was 
used to identify neurons with depolarized mitochondria at baseline. However, we chose to 
determine the effect of mitochondrial modulation on mitochondrial polarization using only the 
50 
 
‘green’ monomeric form (F, 525nm fluorescence), as JC-1 fluorescence of ‘red’ aggregates is 
susceptible to quenching, prone to oxidation and requires ~90 minutes to reach equilibrium 
(versus ~15 minutes for monomers)(Perry et al., 2011). Data were normalized (F1/F0) where F1 is 
the emission fluorescence at 610nm at a given time point and F0 is the baseline emission 
fluorescence at 610nm. This normalization process allowed for the calculation of the relative 
change of mitochondrial membrane potential independent of baseline polarization and JC-1 
loading. In order to determine the percentage of neurons that exhibited meaningful mitochondrial 
depolarization compared to vehicle, we calculated the percentage of neurons whose individual 
maximal F1/F0 was greater than the average maximal F1/F0 for vehicle treatment + 3 * standard 
deviation of the maximal F1/F0 for vehicle treatment. 
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CHAPTER 4 
Contribution of ROS to antimycin A evoked activation of TRPA1 and TRPV1 
 
INTRODUCTION 
Mitochondrial dysfunction and oxidative stress are associated with inflammatory 
pulmonary diseases such as asthma, COPD, and chronic cough(Kirkham and Rahman, 2006).  
Events which cause inflammation such as viral infection and allergen exposure can induce 
oxidative stress through events such as leucocyte activation, mitochondrial dysfunction and 
hypoxia.  Inflammatory signaling pathways including TNFα and IL-1β directly inhibit complexes of 
the mETC, inducing a state mitochondrial dysfunction wherein ROS production is increased as a 
result of slippage of electrons from the mETC and the incomplete reduction of O2(Zell et al., 1997; 
Moe et al., 2004; Mariappan et al., 2009).  While ROS are involved in cellular signaling, excessive 
ROS can oxidize lipids and proteins to cause cellular damage(Stowe and Camara, 2009).  To 
prevent this damage, cells express many antioxidant proteins and contain GSH to reduce ROS 
to H2O2(Stowe and Camara, 2009).  Although ROS activates bronchopulmonary C-fibers and 
inhalation of ROS evokes defensive reflexes in animal models(Ruan et al., 2003; Lin et al., 2010), 
the influence of mitochondrially derived ROS on sensory nerve activation is largely unknown.  In 
addition to ROS, many oxidized lipids including 4-hydroxynonenol, and 4-oxononenal present in 
states of oxidative stress also activate bronchopulmonary C-fibers(Trevisani et al., 2007; 
Andersson et al., 2008; Taylor-Clark et al., 2008a).   
As TRPA1 is directly activated both ROS and oxidized lipids(Andersson et al., 2008; 
Takahashi et al., 2008), it may be responsible for the activation of these fibers by product of 
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oxidative stress.  Previously, we demonstrated that antimycin A activates bronchopulmonary C-
fibers through the activation of TRPA1 and TRPV1 and that there is a correlation between 
mitochondrial O2- production and Ca2+ fluxes in wild type (express TRPA1 and TRPV1) and 
TRPV1-/- (only express TRPA1) neurons but not TRPA1-/- (only express TRPV1) neurons(Stanford 
and Taylor-Clark, 2018).  This provides evidence for the activation of TRPA1 but not TRPV1 by 
mitochondrial ROS.  TRPA1 contains highly reactive cysteines in its cytosolic domain which form 
reversible covalent bonds with electrophiles (ex: ROS) producing channel activation(Macpherson 
et al., 2007; Bahia et al., 2016).  As little evidence suggests that TRPV1 is directly activated by 
ROS(Taylor-Clark and Undem, 2011) it is likely activated via another mechanism.   
Here, we evaluate the impact of ROS on the activation of TRPA1 and TRPV1 downstream 
of mitochondrial modulation with antimycin A.  To evaluate the impact of ROS, we used ROS 
scavengers to neutralize ROS and the ROS-insensitive TRPA1 K620A mutant(Bahia et al., 2016).  
In neurons we scavenged ROS with MnTMPyP (SOD/catalase mimetic) + Tempol (SOD mimetic) 
and isolated the effect of ROS on TRPA1 and TRPV1 by using KO neurons. In transfected 
HEK293 cells we scavenged ROS with the reducing agent dithiothreitol (DTT) and evaluated 
responses in the TRPA1 K620A mutant.   We observed a diminished Ca2+ flux with TRPA1 but 
not TRPV1 in both HEK293 cells and vagal neurons with the use of ROS scavengers.  Although 
diminished, the responses of TRPA1 were not abolished. Due to the high reactivity of TRPA1, we 
evaluated responses in the ROS unresponsive TRPA1 K620A mutant.  Confirming our 
hypothesis, the TRPA1 K620A mutant was not activated during Antimycin A treatment. 
 
RESULTS 
Contribution of ROS to activation 
 The contribution of ROS to the activation of TRPA1 and TRPV1 was evaluated by treating 
cells with MnTMPyP and Tempol to scavenge ROS. This resulted in a decreased Ca2+ flux with 
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TRPA1 (TRPV1-/-, Fig. 4.1 A, B) but not TRPV1 
(TRPA1-/-, Fig. 4.1 C, D) expression only 
conditions.  This is consistent with present 
knowledge regarding the activation of TRPA1 
but not TRPV1 by ROS.  Although the 
percentage of responding neurons was also 
decreased, this was not significant (p > .05).  
This could be explained by the high sensitivity of 
TRPA1 to electrophiles such as ROS and 
products of lipid peroxidation.  Therefore, even 
with large concentrations of ROS scavenging 
agents,  small amounts of remaining  ROS  may  
be capable of activating TRPA1. We further 
investigated the impact of ROS in TRPA1 and 
TRPV1 transfected HEK293 cells and 
scavenged ROS with dithiothreitol (DTT).  In 
both TRPA1 and TRPV1 transfected cells, 
antimycin A produced a large Ca2+ flux (Fig. 4.2 
A-C). As observed in vagal neurons, only a 
portion of HEK293 cells responded to mitochondrial modulation (Fig. 4.2 D-F). Again, scavenging 
ROS diminished but did not abolish Ca2+ fluxes in TRPA1 (p < .05) transfected cells while having 
no effect on TRPV1 (p > .05) responses.  Due to the exceptional reactivity of TRPA1 to ROS, 
evaluated the responses in the ROS unresponsive TRPA1 K620A mutant.  Indeed, with this ROS 
unresponsive mutant the Ca2+ flux (p > .05 vs non-transfected) observed during antimycin A 
treatment was abolished (Fig 4.3 A-B).  
Figure 4.1: Scavenging ROS decreases 
TRPA1 but not TRPV1 responses. The (A 
and C) percentage of neurons responding to 
antimycin A treatment and (B and D) 
magnitude of Ca2+ fluxes in TRPV1-/- (green, 
A and B) and TRPA1-/- (red, C and D) vagal 
neurons. Ca2+ flux magnitude, but not the 
percentage of neurons responding was 
decreased in TRPV1-/- but not TRPA1-/- 
neurons.  $ denotes significant difference 
between MnTMPyP + Tempol and control (p 
< .05). 
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DISCUSSION  
ROS are produced at increased levels in individuals with pulmonary disease.  Additionally, it has 
been shown that H2O2 activates bronchopulmonary C-fiber fibers(Ruan et al., 2003; Lin et al., 
2010).  However, the direct influence of mitochondrially derived ROS on sensory nerve activity 
has not been previously studied.  We observed decreased Ca2+ fluxes in the presence of ROS 
scavengers with TRPA1 but not TRPV1 in both vagal neurons and HEK293 cells.  This suggests 
that TRPA1 activation is ROS dependent while TRPV1 is activated through a ROS-independent 
mechanism.  Although some studies suggest that ROS can activate TRPV1, these studies have 
relied on whole cell techniques and there are no reports of direct ROS-induced TRPV1 activation 
of using excised patch clamp techniques.  These studies also used H2O2 at concentrations (1mM 
and 10mM) which exceed physiologic ROS levels(Taylor-Clark and Undem, 2011).  As ROS  
 
Figure 4.2 Scavenging ROS with DTT decreases TRPA1 but not TRPV1 responses in 
HEK293 cells. Antimycin A evoked cytosolic Ca2+ fluxes in (A) TRPA1 and (B) TRPV1 
transfected HEK293 cells were decreased in TRPA1 but not TRPV1 expressing cells with DTT 
treatment.  With (C) bar graph of mean +/- SEM Ca2+ flux and Ca2+ flux density histograms for 
(D) TRPA1, (E) TRPV1 and (F) non-transfected cells. * denotes significant difference from non-
transfected cells (p < .05); $ denotes significant difference between + DTT and control (p < .05). 
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activates cellular signaling pathways 
through the activation of 
serine/threonine kinases (such as 
PKC), and NF-kB(Stowe and 
Camara, 2009), this excess amount 
of ROS could activate signaling 
pathways in a manner which is not 
present under physiologic conditions.   
As several isoforms of PKC are 
activated by ROS(Cosentino-Gomes 
et al., 2012), this provides a possible 
mechanism for the activation of TRPV1 by H2O2 in whole cell studies.   In our experiments using 
antimycin A, ROS scavenging did not affect Ca2+ fluxes in TRPV1 expressing vagal neurons or 
HEK293 cells, its activation downstream of mitochondrial modulation is likely ROS independent. 
In the case of TRPA1, ROS scavengers reduced Ca2+ fluxes, suggesting a role for ROS.  
Interestingly, the Ca2+ fluxes in vagal neurons and HEK293 cells expressing TRPA1 were not 
abolished.  For these experiments, we used the maximal concentrations of ROS scavengers 
which were previously used in the literature.  In the case of DTT, we were unable to increase the 
concentration of DTT as higher concentrations activate TRPV1(Susankova et al., 2006).  The lack 
of complete abolishment of the TRPA1 response with DTT could be due to its participation in 
redox cycling.   Interestingly, DTT reduced TRPA1 responses in HEK293 cells but not in vagal 
neurons (vagal neuron data not shown).  The underlying reason the diminished Ca2+ fluxes in 
HEK293 cells but not TRPA1 only expressing vagal neurons is unknown.  It is possible that cellar 
components present in vagal neurons but not HEK293 cells drive redox cycling and prevent our 
ability to scavenge ROS and electrophilic compounds.  There may also be differences between 
 
Figure 4.3: The ROS unresponsive TRPA1 K620A 
mutant did not respond to antimycin A treatment.  
Cytosolic Ca2+ fluxes expressed as (A) a time course 
and (B) as mean +/- SEM maximal Ca2+ response. $ 
denotes significant difference from TRPA1 transfected 
control (p > .05). 
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vagal neurons and HEK293 cells in regard to baseline cellular conditions as cell culture alters 
both mitochondrial function and cellular signaling.  These unknown differences between vagal 
neurons and transfected HEK293 cells may result in differential effects of antimycin A and ROS 
scavengers in these systems which may account to the diminished Ca2+ fluxes with DTT in 
HEK293 cells but not vagal neurons.  Another possibility for these differences is that HEK293 
cells were transfected with human TRPA1 and vagal neurons were from mice.  However, both 
human and mouse TRPA1 are highly sensitive to ROS-mediated activation(Macpherson et al., 
2007; Taylor-Clark et al., 2007).  Therefore, the differences between mouse and human TRPA1 
likely do not affect the mechanism underlying TRPA1 activation by antimycin A. 
In addition to DTT and MnTMPyP + Tempol, we evaluated Ca2+ fluxes in TRPA1 neurons 
with 10μM lipoic acid and 2000U/mL pegylated SOD + pegylated catalase 2000U/mL (data now 
shown).  For ROS scavengers tested, we used the largest concentrations observed in prior 
literature, all of which reduced ROS-mediated responses(Beckman et al., 1988; Foo et al., 2011; 
Lu et al., 2017).  However, these failed to diminish Ca2+ fluxes.  It has been previously shown that 
SOD and catalase can reduce antimycin A-evoked apoptosis but not substantially reduce ROS 
production or decrease GSH depletion(Park et al., 2007).  This demonstrates that Antimycin A-
evoked ROS is difficult to scavenge.  Thus, in the case of TRPA1, effectively scavenging ROS to 
abolish activation may not be possible with current methods.  This indicates that our ability to 
diminish but not abolish TRPA1 mediated responses is likely not due to the presence of two 
mechanisms (a ROS-dependent and ROS-independent mechanism), or the inhibition of TRPA1 
by ROS scavenging agents.  Work in our lab has demonstrated that TRPA1 exhibits exceptionally 
high reactivity to electrophilic activation occurring at a rate of 500–900 M−1s−1, over 6,000-fold 
faster than that of antioxidant enzymes and GSH (33 M−1s−1)(Bednar, 1990; Bahia et al., 2016).  
Therefore, the possibility remains that even with high concentrations of ROS scavengers and 
reducing agents, the small amounts of ROS remaining may activate TRPA1.  Additionally, ROS 
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oxidizes cellular lipids which also activate TRPA1.  Therefore, it is possible that these compounds 
be generated before ROS can be adequately scavenged and activate TRPA1.   
Due to the difficulties involved with assessing the ROS induced activation of TRPA1, we 
evaluated responses in a ROS and electrophile unresponsive human TRPA1 K620A 
mutant(Bahia et al., 2016).  In these experiments, the antimycin A evoked Ca2+ flux was abolished.  
This seems to indicate that the diminished but not abolished responses were due to our inability 
to effectively scavenge ROS.  However, the lack of reduced Ca2+ flux with TRPV1 is likely not due 
to high reactivity.  As previously discussed, there is little evidence to suggesting that TRPV1 is 
activated by ROS and its ROS-induced activation has only been demonstrated in intact cells using 
concentrations which far exceed physiologic ROS(Taylor-Clark and Undem, 2011). This is in 
direct contrast to TRPA1 where there is a large body of evidence for its direct activation by ROS 
and electrophilic compounds present in oxidative states.  Therefore, our inability to abolish TRPV1 
activation evoked Ca2+ fluxes is not due to our inability to scavenge ROS.  This suggests an 
alternate mechanism for the activation of TRPV1, likely involving activation of cellular signaling.  
As TRPV1 is sensitized by PKC and ROS can activate several isoforms of PKC(Knapp and Klann, 
2000; Wang et al., 2015), this may result in TRPV1 activation.  However, the expression of PKC 
isoforms is heterogenous and as isoforms differ based on the factors required for activation and 
site of action(Parker, 2004).  As PKC inhibitors have varying specificities for these isoforms and 
often have off-target effects, more studies on the activation of PKC by antimycin A in vagal 
neurons are required before studying the effects on TRPV1 activation.   
Interestingly, only a portion TRPV1 and TRPA1 HEK293 cells and vagal neurons 
responded during antimycin A treatment.  The reason underlying this is unknown.  Although these 
differential responses could be a result of differential protein expression in vagal neurons, this is 
unlikely given that this phenomenon was also observed in HEK293 cells.  In the previous chapter, 
we found that many of TRPA1 only expressing neurons which failed to exhibit a Ca2+ flux exhibited 
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increased mitochondrial ROS production.  This is particularly interesting given the exceptionally 
high sensitivity of TRPA1 to ROS and our difficulties with adequately scavenging ROS.  As we 
specifically measured mitochondrial ROS, it is possible that ROS were scavenged by cellular 
antioxidants prior to their reaching the plasma membrane.  Furthermore, antimycin A evokes O2- 
production on the matrix and the intermembrane space faces of the inner mitochondrial 
membrane(Muller et al., 2004).  Therefore, both mitochondrial ROS scavenging and the ability of 
ROS to diffuse to the plasma membrane may have an effect on TRPA1 activation.  Another 
possible influence is cytosolic Ca2+ which can both potentiate and inhibit TRPA1.  Therefore, 
mitochondrial Ca2+ release may affect the sensitivity of TRPA1 to activation by ROS.  It is also 
possible that cellular signaling pathways may alter the sensitivity of TRPA1.  Unfortunately, given 
the complexities regarding the in situ study of mitochondrial function and activation of ion channels 
studies of the mechanisms behind these differential responses are exceptionally difficult.  Another 
complication is that mitochondrial inhibition has varying effects based on not only the site of 
inhibition, but also the tissue or origin and baseline metabolic status(Tahara et al., 2009). 
Therefore, the reasons underlying these differential effects remain unknown and require much 
further research. 
 
UNIQUE METHODS 
Scavenging ROS 
To scavenge ROS, neurons were pre-treated with 1mM tempol for 45 minutes at 37oC, 
then transferred to the microscope and perfused with 50μM MnTMPyp + 100μM tempol for 15 
minutes prior to the start of imaging and washed off 1 minute after the completion of antimycin A 
treatment.  In HEK293 cells, ROS was scavenged with 100μM DTT with treatment commencing 
1 minute prior to antimycin A exposure and ending 2 minutes after the completion of antimycin A 
treatment.   
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CHAPTER 5 
Improving roGFP1 sensitivity by incorporation of selenocysteine at position 147 
 
INTRODUCTION 
The study of reactive oxygen species (ROS) signaling has received increased attention in 
the pathogenesis of a wide variety of pathophysiologies such as neurodegeneration, cancer, and 
inflammation(Lin and Beal, 2006; Zhang et al., 2015; Garaude et al., 2016). However, 
investigations into ROS signaling has been hindered by a lack of available methods to accurately 
measure small and localized ROS fluctuations. Current methods to measure ROS include redox-
sensitive dyes and genetically-encoded reporter proteins such as redox-sensitive green 
fluorescent protein (roGFP)(Dooley et al., 2004; Chen et al., 2011; Guo et al., 2014). 
Unfortunately, redox-sensitive dyes often lack the ability to localize in sub-cellular compartments 
and are generally incompatible with in vivo use. Genetically-encoded reporter proteins such as 
roGFP have been used in vivo and targeted to many organelles, but they lack the sensitivity of 
dyes(Breckwoldt et al., 2014; Wagener et al., 2016). Although roGFP2, a variant of 
roGFP, is sensitive to hypoxia-mediated ROS production, its responses are slow(Dooley et al., 
2004; Waypa et al., 2011), suggesting significant limitations for the detection of local, small-scale, 
and transient fluctuations involved in physiologic ROS signaling. This highlights the need to 
develop reporter proteins with increased redox-sensitivity. 
roGFP1 is a commonly used variant of roGFP that is largely unaffected by pH and 
produces a strong fluorescent signal(Roma et al., 2012). Additionally, roGFP1 has been targeted 
and optimized for use in cellular compartments such as the mitochondria and endoplasmic 
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reticulum(Hanson et al., 2004; Delic et al., 2010). roGFP1 contains two redox-sensitive cysteines 
at amino acids 147 and 204 which serve as a biological switch. Oxidation and reduction of these 
cysteines shifts fluoresce between two excitation maxima (approximately 405 and 470nm)(Dooley 
et al., 2004; Hanson et al., 2004).  As such, the cellular redox state is expressed as a ratio of 
these excitation maxima (405/470). Upon exposure to ROS, the redox-sensitive cysteines are 
oxidized, resulting in intramolecular disulfide bond formation, increased fluorescence at 405nm 
and decreased fluorescence at 470nm (increased 405/470 ratio)(Hanson et al., 2004).  Cellular 
glutathione reductase reduces the disulfide bond, restoring fluorophore structure and fluorescent 
properties to the pre-oxidized state.  
These ratiometric and reversible properties of roGFP1 make it well-suited to measure 
cellular ROS. However, its lack of sensitivity renders it unsuitable for detecting ROS fluctuations 
involved in physiologic signaling(Dooley et al., 2004). One factor contributing to the relative 
insensitivity of roGFP1 is the protonation of its redox-sensitive cysteines under physiologic cellular 
conditions: only deprotonated cysteines are able to react with ROS(Roberts et al., 1986).  To 
overcome this barrier, several attempts have been made to decrease the pKa (from ~8.2) of the 
roGFP1 cysteines by mutating surrounding amino acids(Cannon and Remington, 2006). 
Unfortunately, the resulting proteins also lacked the sensitivity to detect small ROS 
fluctuations.  An alternative approach to increase the sensitivity of roGFP1 is to replace the 
fluorophore cysteines with selenocysteine, a more reactive nucleophile with a lower pKa (5.5 vs 
8.2)(Byun and Kang, 2011). Selenocysteine is capable of forming bridges upon oxidation with 
either selenocysteine or cysteine(Müller et al., 1994).  These properties indicate that incorporation 
of selenocysteine has the potential to increase the sensitivity of roGFP1. 
Selenocysteine incorporation into proteins is more complex and inefficient compared 
to insertion of canonical amino acids. Selenocysteine incorporation occurs at UGA codons, which 
typically serve to stop protein translation(Chambers et al., 1986).  Thus, incorporation requires 
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additional elements including a selenocysteine insertion sequence (SECIS) in the 3’ untranslated 
region of the mRNA and a selenocysteine specific elongation factor(Zinoni et al., 1990; 
Tujebajeva et al., 2000).  Even in the presence of all required elements, insertion remains 
inefficient with translation stalling at the UGA codon, resulting in protein truncation. To increase 
incorporation, selenoproteins can be co-expressed with selenocysteine binding protein 2 (SBP2), 
which helps coordinate the proximity of the required insertional elements. This results 
in increased insertion efficiency and decreased truncation(Copeland et al., 2000; Copeland et al., 
2001).  
Here we attempted to increase the sensitivity of roGFP1 by mutating the functional 
cysteine (at position 147) to selenocysteine (roGFP1-Se147).  To allow for selenocysteine 
insertion, we incorporated a 3’ SECIS element and supplemented media with sodium selenite. To 
maximize expression of roGFP1-Se147, we developed two expression systems (selenovectors), 
both of which co-expressed SBP2 and roGFP1-Se147. We successfully expressed roGFP1-
Se147 which exhibited similar excitation and emission spectra to roGFP1. Though roGFP1-
Se147 demonstrated increased sensitivity, it exhibited a poor dynamic range and photoinstability. 
 
RESULTS 
Western Blot  
HEK293T cells were transfected with roGFP1-N1 (control vector), roGFP1-pLuc01, 
roGFP1-Se147pLuc01, roGFP1-pSel, or roGFP1-Se147pSel (Fig. 5.1). roGFP1 was highly 
expressed in the control vector (roGFP1-N1).  Interestingly, roGFP expression was reduced with 
use of both the selenovectors (roGFP1-pSel, and roGFP1-pLuc01). Expression of roGFP1-
Se147 was limited but detectable for both selenovectors, although expression was consistently 
higher with the roGFP1-Se147pSel vector. Previous studies have demonstrated protein 
truncation at selenocysteine insertion sites(Tujebajeva et al., 2000; Mehta et al., 2004; 
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Novoselov et al., 2007).  However, no evidence of protein truncation was observed for the 
selenoproteins. 
 
Spectral analysis 
Using transfected HEK293T cells suspended in PBS, we evaluated the excitation 
(detected at 530nm, Fig. 5.2 A) and emission spectra (excited at 405nm, Fig. 5.2 B) of GFP, 
roGFP1-pSel and roGFP1-Se147pSel. Redox-insensitive GFP exhibited a large excitation peak 
at ~480nm and roGFP1-pSel exhibited two excitation peaks with the largest peak at ~405nm and 
a smaller peak at ~475nm, consistent with previous studies(Dooley et al., 2004). The excitation 
spectrum for roGFP1-Se147pSel was similar to roGFP1-pSel with its maximum at ~405nm. All 
proteins exhibited similar emission spectra with a single maximum at ~530nm. 
 
Figure 5.2: Spectra of GFP, roGFP1, and roGFP1-Se147. Constructs expressed in HEK293T. 
(A) Excitation spectra, measured at 530nm. (B) Emission spectra, excited by 405nm.   
 
Figure 5.1: Expression of roGFP1 constructs. Western blot of lysates from HEK293 cells 
following expression of roGFP1-N1, roGFP1-pLuc, roGFP1-Se147pLuc01, roGFP1-pSel, 
roGFP1-Se147pSel and a non-transfected control. B-actin (red) used as a loading control. 
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Functional analysis 
Though expression of roGFP1-Se147pSel was limited according to our western blot data, 
sufficient fluorescent signals were observed in living HEK293 cells to evaluate the responsiveness 
of roGFP1-Se147pSel to oxidation and reduction (Fig. 5.3). Omission of sodium selenite from the 
culture prevented roGFP1-Se147pSel expression (data not shown). roGFP1-pSel was insensitive 
to oxidation with 3µM H2O2, but oxidation with 30, and 300µM H2O2 evoked substantial increases 
in the 405/470 ratio, which was reversed by the reducing agent dithiothreitol (DTT) (3mM). The 
selenoprotein, roGFP1-Se147pSel, exhibited minor responses to oxidation with 3, 30, and 300µM 
hydrogen peroxide as well as to reduction with 3mM DTT, indicating a lack of dynamic range of 
the fluorophore. In comparison to roGFP1-pSel, roGFP1-Se147pSel exhibited an elevated 
baseline 405/470 ratio, which increased by ~5% under resting conditions until leveling off after 2 
minutes, suggesting photoinstability of the selenoprotein. 
 
In order to determine the redox-sensitivity of roGFP1-Se147pSel while minimizing any 
excitation-associated photoinstability, we reduced the exposure time and frequency of the 
sequential excitation. As the baseline for roGFP1-Se147pSel was greater than roGFP1-pSel, we 
normalized results (fold change baseline) to facilitate comparison between the constructs. Again, 
 
Figure 5.3: Response of roGFP1 selenoprotein to oxidation and reduction. (A) Mean +/- 
SEM of the 405/470 ratio of HEK293 cells transfected with roGFP1-Se147pSel (red, n=52) and 
roGFP1-pSel (blue, n=220) treated with 3, 30, and 300µM H2O2 followed by 3mM DTT. (B) and 
(C) Representative pseudocolor image of 405/470 ratio of HEK293 cells transfected with 
roGFP1-pSel (B) and roGFP1-Se147pSel (C) at baseline and after 300µM H2O2. 
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roGFP1-pSel exhibited a robust response to ≥30µM H2O2 (p<0.01), but again failed to respond to 
3µM H2O2 (p>0.05) (Fig. 5.4 A).  However, roGFP1-Se147pSel exhibited an increased normalized  
405/470 ratio in response to ≥300nM H2O2 (p<0.01) (Fig. 5.4 B). Thus, the threshold for H2O2 
detection for roGFP1-Se147pSel was approximately 100-fold lower than that of roGFP1-pSel. 
Curve fitting of the dose-response relationships showed that roGFP1-Se147pSel was 
approximately 20 times more sensitive to oxidation with H2O2 compared to roGFP1-pSel (EC50 
of 9.8 x 10-7M and 2.0 x 10-5M, respectively)(Fig. 5.4 C). Consistent with our previous data, 
roGFP1-Se147pSel demonstrated a greatly diminished dynamic range compared to roGFP1-pSel 
(Fig. 5.4 A and B). 
 
Figure 5.4: Response of roGFP1 selenoprotein to oxidation and reduction with reduced 
recording frequency. (A) HEK293 expressing roGFP1-pSel (n=62 to 263). (B) HEK293 
expressing roGFP1-Se147pSel (103 to 346). Data are normalized mean +/- SEM 405/470 ratio 
in response to buffer, and 30nM to 3mM H2O2. * denotes difference at 240 seconds in normalized 
ratio between different treatment groups (p<0.01). (C) Concentration-response relationship of 
H2O2 treatment in roGFP1-pSel and roGFP1-Se124pSel expressing HEK293 cells fitted using a 
non-linear regression. EC50 for roGFP1-pSel and roGFP1-Se147pSel was 2.0 x 10-5 (R2 of 0.94) 
and 9.8 x 10-7 (R2 of 0.97), respectively.   
 
Finally, we evaluated the sensitivity of the selenoprotein to endogenous ROS evoked by 
the mitochondrial complex III inhibitor antimycin A(Turrens et al., 1985b; Gyulkhandanyan and 
Pennefather, 2004). Antimycin A (10µM) failed to increase the 405/470 ratio of roGFP1-pSel 
(p>0.05, compared to untreated cells) (Fig. 5.5 A). Whereas antimycin A increased the 405/470 
ratio of roGFP1-Se147pSel (p<0.01), compared to the 0.1% ethanol vehicle or untreated control) 
(Fig. 5.5 B). Unexpectedly, the 0.1% ethanol vehicle decreased the roGFP1-pSel 405/470 ratio 
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(p<0.01) but this did not occur with roGFP1-Se147pSel (p>0.05). Overall, the data suggest that 
roGFP1-Se147pSel is sufficiently sensitive to detect endogenous oxidative stress produced 
downstream of mitochondrial dysfunction. 
 
Figure 5.5: Response of roGFP1 selenoprotein to mitochondrial oxidation with antimycin 
A. (A) HEK293 expressing roGFP1-pSel (n=221 to 363). (B) HEK293 expressing roGFP1-
Se147pSel (n=237 to 346). Data are normalized mean +/- SEM 405/470 ratios in response to 
buffer (blue lines), 0.1% ethanol vehicle (green lines), and 10uM antimycin A (red lines). * denotes 
significant difference in normalized ratio between different treatment groups (repeated measures 
ANOVA, p<0.01). n.s. denotes no significant difference between groups (p>0.05).  
 
Redox titration 
As roGFP-se147pSel exhibits decreased expression as compared to roGFP1-pSel and roGFP1-
N1, we concentrated the protein to perform a redox titration.  To protect the selenocysteines and 
cysteines, we used DTT in the cellular lysis buffer which was washed off prior to performing the 
titration during our buffer exchange step, this DTT was removed along with any cellular 
glutathione. The roGFP1-pSel protein was successfully concentrated (Fig. 5.6 A) and we 
performed a redox titration using a 10mM lipoate buffer with increasing ratios oxidized: reduced 
lipoate (from 0:10 to 10:0 in increments of 1mM).  The 405/470 excitation ratios and fluorescent 
spectra obtained during these experiments are presented in Fig. 5.6 B and C.  Using these data, 
we calculated the redox potential to be -290mV, similar to results obtained in other labs which 
calculated the redox potential to be -288mV (Hanson et al., 2004).  Although our results are 
similar, we did not use a known concentration of protein and our measurement of redox potential 
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is inaccurate.  Additionally, even with concentration, we were unable to obtain sufficient signal to 
evaluate the redox potential of roGFP1-Se147 (Fig. 5.7 A and B). 
 
 
Figure 5.6: Concentration and redox titration of roGFP1-pSel. (A) 405/470 ratio and (B) 
excitation spectra at varying ratios of oxidized: reduced 10mM lipoate buffer. 
 
 
DISCUSSION  
The mutation of cysteine to selenocysteine (UGA) at position 147 in both selenovectors 
yielded a full-length protein (~27kDa), indicating successful incorporation of the selenocysteine. 
We found that the pSelExpress1 vector (contains both the selenoprotein and SBP2) produced 
relatively more selenoprotein, consistent with its reported increased efficiency(Novoselov et al., 
2007). Though there was no indication of truncation, this could be a result of polyclonal primary 
antibody insensitivity to this portion of roGFP1, or levels of truncated protein below the detection 
threshold. Spectral analysis revealed similar excitation and emission spectra for both roGFP1 and 
roGFP1-Se147, indicating that the 405/470 ratio was appropriate for determining redox-sensitivity 
of roGFP1-Se147. Despite the relatively low selenoprotein expression, sufficient roGFP1-Se147 
 
Figure 5.7: Redox titration of concentrated roGFP-Se147pSel.  (A) 405/470 ratio and (B) 
excitation spectra at varying ratios of oxidized: reduced 10mM lipoate buffer.  Due to the poor 
signal to noise ratio was obtained and we were unable to calculate the redox potential. 
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was produced to perform fluorescent live cell imaging of transfected HEK293 cells. Consistent 
with previous reports roGFP1 responded robustly to substantial oxidation caused by 
concentrations of ≥30µM H2O2 but failed to respond to either 3µM H2O2 or 10µM antimycin 
A(Dooley et al., 2004).  roGFP1-Se147 demonstrated a 100-fold lower H2O2 detection threshold 
than roGFP1. Additionally, roGFP10Se147 demonstrated sufficient sensitivity to detect 
mitochondrial ROS evoked by 10µM antimycin A. This indicates increased sensitivity of the 
selenoprotein to oxidation with both exogenous and endogenous ROS. 
Unfortunately, roGFP1-Se147 exhibited a decreased dynamic range and photoinstability. 
By decreasing the excitation exposure to roGFP1-Se147, we were able to resolve stimuli-induced 
responses. However, these characteristics limit the usefulness of roGFP1-Se147 as an effective 
reporter. Both the diminished dynamic range and photoinstability can likely be attributed to 
unforeseen structural consequences resulting from the replacement of cysteine with 
selenocysteine. Other groups have shown that roGFP1 exhibits some photoswitching with 
prolonged exposure to 405nm light(Schwarzländer et al., 2008). This results in a shift toward the 
470nm excitation maximum independent of disulfide bond formation. It is possible that 
selenocysteine altered the protein structure in such a way that it worsened the existing 
photoinstability of roGFP1. 
We were unable to perform a successful redox titration of roGFP1-Se147.  The main 
reason for this is our inability to concentrate roGFP1-Se147 and obtain a high signal to noise ratio.  
While we were able to concentrate our sample, this did not provide a sufficient signal to perform 
a redox titration.  However, we were able to concentrate roGFP1-pSel and perform a redox 
titration.  We calculated the redox potential of roGFP1 to be -289mV which is similar to results 
obtained in other labs indicating a redox potential of -288mV(Hanson et al., 2004) although we 
did not use a known protein concentration.  Other than our use of an unknown protein 
concentration, another reason for the slight discrepancy in the calculated redox potential is that 
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other experiments regarding redox potential were performed in an oxygen free environment while 
ours were performed in room air.  Unfortunately, performing a redox titration on roGFP1-Se147 
was not possible due to a low signal to noise ratio.  This suggests that roGFP1-Se147 may have 
degraded or lost fluorescence during the concentration and buffer exchange procedure which was 
used to remove cellular glutathione.  This low signal meant that we were unable to determine 
whether the 405/470 excitation ratio was altered by reduction or oxidation in the lipoate buffer.   
Selenocysteine incorporation occurs in approximately 25 native human proteins, the vast 
majority of which incorporate a single selenocysteine residue(Kryukov et al., 2003). 
Selenocysteine incorporation requires multiple elements including SECIS, a selenocysteine 
specific elongation factor and selenium. As such, the incorporation efficiency of selenocysteine is 
reduced compared to that of canonical amino acids(Leonard et al., 1996; Lesoon et al., 1997; 
Gonzalez-Flores et al., 2010). Here, we found that expression levels of roGFP1-Se147 were 
sufficient, yet the functionality (dynamic range, photostability) was disrupted. Previous studies 
have successfully inserted selenocysteine (in the place of cysteine) into proteins normally lacking 
selenocysteine. This has been performed in numerous proteins including luciferase, rat growth 
hormone receptor and the human thyroid hormone receptor without substantially reducing 
functional responses(Leonard et al., 1996; Latrèche et al., 2009). Furthermore, replacement of 
cysteine with selenocysteine has been shown to increase catalytic activity in mouse glutoredoxin 
and plant phospholipid hydroperoxide glutathione peroxidase(Hazebrouck et al., 2000; Ge et al., 
2009). This is consistent with the greater redox reactivity of selenocysteine. These reports 
demonstrate that selenocysteine incorporation in non-selenoproteins is generally feasible and 
yields functional proteins. Thus, the decreased functionality of roGFP1-Se147 is likely a specific 
effect on roGFP1, rather than a general property of non-native selenocysteine incorporation. 
In conclusion, we present a selenocysteine-containing mutant of roGFP1 that displays 
increased sensitivity to ROS but decreased dynamic range and photoinstability. The development 
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of probes with increased sensitivity is a pre-requisite for the understanding of the multiple roles of 
ROS and oxidative stress in physiological and pathophysiological processes. 
 
UNIQUE METHODS 
Creation of roGFP1 selenoprotein 
All roGFP constructs were derived from roGFP1-N1 (generous gift from Dr. SJ Remington, 
University of Oregon). To maximize selenoprotein expression, we used two systems for 
expression of the roGFP1 selenoprotein (roGFP1-Se147): pLuc01 and pSel. Both selenoprotein 
expression vectors (selenovectors) contained a 3’ SECIS element.  To increase selenocysteine 
incorporation, roGFP1-Se147 was co-expressed with SBP2 by either co-transfection of a second 
plasmid (pLuc01 system) or co-expression on the same vector (pSel system). The pLuc01 system 
involved co-transfection of two plasmids: the LucC258U/wtP plasmid containing a 3’ PHGPx 
SECIS element (generous gift from Dr. P Copeland, Rutgers)(Mehta et al., 2004), and the 
hSBP2/V5-HIS plasmid (generous gift from Dr. P Copeland, Rutgers), contained human SBP2. 
roGFP1 was subcloned from roGFP1-N1 into LucC258U/wtP (generous gift from Dr. P Copeland, 
Rutgers) plasmid using HindIII and PacI (inserted using primer) restriction sites (roGFP1-
pLuc01)(Hanson et al., 2004; Mehta et al., 2004). Custom designed primers with a single point 
mutation were then used to mutate roGFP1 nucleic acid 441 from C to A, creating a UGA codon 
for selenocysteine insertion (roGFP1-Se147pLuc01). The pSel system utilized a dual expression 
in the pSelExpress1 plasmid (generous gift from Dr. V Gladyshev, Brigham and Women's 
Hospital, Harvard Medical School) which contains a modified Toxoplasma gondii SECIS element 
and the C terminal functional domain of rat SBP2(Novoselov et al., 2007). Both roGFP1 and 
roGFP1-Se147 were PCR amplified from the pLuc01 expression system and inserted into 
pSelExpress1 using XbaI and HindIII restriction sites (roGFP1-pSel and roGFP1-Se147pSel). 
The success of all insertions and mutations were confirmed by sequencing.  
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Cell Culture 
HEK293 cells were used for functional analysis.  HEK239T cells were used for all other 
studies to maximize protein expression.  Cells transfected with roGFP1-Se147 constructs were 
supplemented with 10nM sodium selenite at the time of transfection to allow for selenocysteine 
insertion.  For general HEK293 cell culture methods, see common methods.   
 
Western Blot 
Cells were transfected with roGFP1-pLuc01, roGFP1-Se147pLuc01, roGFP1-pSel, 
roGFP1-Se147pSel, and roGFP1-N1 (vector control).  Transfected cells were lysed using lysis 
buffer (50mM TRIS, 150mM NaCl, 2% TritonX-100, and 0.05% SDS) and protein collected via 
centrifugation.  The amount of total protein was calculated using a bicinchoninic acid assay 
(Thermo Scientific, Rockford, IL).  Samples were diluted to 1ug/ul in Licor 4X protein sample 
loading buffer.  The diluted protein (10µg) was loaded onto a Mini-Protean TGX 4-20% precast 
gel (Bio-Rad, Hercules, CA). Following electrophoresis, proteins were transferred onto a 
nitrocellulose membrane using a Trans-Blot Turbo transfer pack (Bio-Rad, Hercules, CA) on a 
Trans-Blot Turbo (Bio-Rad, Hercules, CA). Membranes were blocked in Odyssey blocking buffer 
(LI-COR, Lincoln, NE) for 60 minutes then incubated in 1:500 chicken anti GFP (Aves cat# GFP-
1020) and 1:500 mouse anti β–actin (Novus, Minneapolis, MN, Cat# NB600-501) diluted in 
Odyssey blocking buffer + 0.15% Tween-20 overnight at 4ᵒC. Gels were washed 6x10 minutes 
with PBS + 0.1% Tween-20 then incubated the secondary antibodies:  1:20,000 donkey anti 
mouse 680 (LI-COR, Lincoln, NE, Cat# 926-68022) and 1:20,000 donkey anti chicken 800 (LI-
COR, Lincoln, NE, Cat# 926-32218) diluted in in Odyssey blocking buffer + 0.15% tween +0.02% 
SDS.  After six washes with PBS + 0.1% Tween-20, membranes were imaged using a Licor 
Odyssey (LI-COR, Lincoln, NE) to evaluate expression of the roGFP1 and roGFP1-Se147 
constructs. 
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Spectral analysis 
Cells were transfected with pEGFP-N1 (Clonetech, Mountain View, CA), roGFP1-pSel, or 
roGFP1-Se147pSel. To obtain a cell suspension for analysis, cells were lifted with Accutase, spun 
down then resuspended in 600µl PBS (250,000 cells for GFP control, and 750,000 roGFP1-pSel 
and roGFP1-Se147pSel transfected cells). 100µl of each cell suspension was loaded into a well 
on an optical 96 well plate.  Scans were performed using a Synergy Mx Microplate Reader 
(BioTek, Winooski, VT). Excitation scans between 350-520nm were detected at 530nm, emission 
scans were detected between 430 and 700nm following excitation at 405nm. For analysis, 
background fluorescence (non-transfected cells) was subtracted from the sample fluorescence.  
To normalize the data we calculated the percent maximal relative fluorescence units (RFU) of the 
background subtracted data. 
 
Functional Analysis 
Transfected cells on Poly-D Lysine and laminin coverslips were placed in a chamber and 
perfused with 10mM HEPES buffer (154mM NaCl, 1mMKCl, 0.5M MgCl2, 2.5mM CaCl2, 5.6mM 
D-glucose) at 33-34ᵒC and evaluated for changes in cellular redox state.  Drugs were diluted in 
HEPES (DTT, 3mM, 2mM; H2O2, 30nM to 3mM; Antimycin A, 10µM).  Cells were monitored using 
sequential excitation at 405 and 470nm every 6 or 60 seconds with emissions recorded at 510nm 
using microscopy (CoolSnapHQ2; Photometrics Surrey, BC, Canada), and analyzed using NIS 
elements software (Nikon, Melville, NY).   
 
Redox Titration 
Cells were transfected with roGFP1-pSel, and roGFP1-Se147pSel (see cell culture).  After 
24 hours, cells were lifted with Accutase, then transferred to a conical tube then spun at 700 x g 
for 2 minutes.  Each pellet was resuspended in chilled PBS + 100ug/ul Saponin + 0.5mg/ml Roche 
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Complete Mini protease inhibitor + 1mM DTT and incubated on ice for 3 minutes.  The use of 
saponin permitted extraction of roGFP1 from cells while leaving larger proteins inside the cell. 
The DTT was used to protect the cysteines and selenocysteines of roGFP1-Se147pSel and 
roGFP-pSel from oxidation during extraction.  The saponin-permeabilized cells were centrifuged 
at 700 x g for two minutes.  The supernatant was removed and placed in a microcentrifuge tube 
and spun at 1400g for 10 minutes at 4oC to remove any remaining debris.  Again, the supernatant 
was removed, then placed in a pierce spin column (10,000 MW cutoff), volume adjusted to 6mL 
and centrifuged at 4oC at 4000 x g until the volume was reduced 90-95%.  To exchange the buffer 
and remove DTT, remaining liquid was diluted to 2mL with 75mM HEPES + 125mM KCl + 1mM 
EDTA and centrifuged again at 4oC at 4000 x g until the volume was reduced by 90-95%.  The 
remaining liquid was removed and volume adjusted to account for variations in cellular growth.  
For each condition, 180μl of sample was pipetted into each of 11 wells on a 96 well optical plate 
with 20μl of the appropriate lipoic acid buffer (10mM final) and incubated at room temperature for 
one hour.   
An excitation scan (350-520nm excitation; 530nm emission) was performed using a 
Synergy Mx Microplate Reader (BioTek, Winooski, VT) using the same procedure as for the 
spectral analysis. For analysis, background fluorescence (non-transfected cells) was subtracted 
from the sample fluorescence.  To calculate the 405/470 ratio, we used the average of 403-407 
excitation and 468-472 of the normalized data (see spectral analysis) to minimize the impact of 
the low signal to noise ratio caused by low protein expression.   For each titration increment (from 
0:10 to 10:0) we calculated:  Y = (Rn-Rmin)/(Rmax-Rn). 
 
 
Rn 405/470 ratio at a specific oxidized: reduced buffer ratio 
Rmin minimum 405/470 ratio (0:10 reduced) 
Rmax is the maximal 405/470 ratio (10:0 oxidized) 
73 
 
 
A plot of Y versus log([oxidized] / [reduced]) was generated.  The buffer ratio required to 
achieve 50% protein oxidation (A) was determined by calculating the Y intercept of the trendline.  
Keq was calculated form the following equation:  log Keq=log(F470red)/(F470ox)– log A. 
 
 
F470red fully reduced protein at 470nm excitation 
F470ox fully oxidized protein 470nm excitation 
A buffer ratio where the protein is 50% oxidized 
   
The equilibrium potential was calculated using the Nernst equation:  E’= E’0 - (RT/nF) ln Keq. 
 
 
E’ equilibrium potential 
E’0 redox potential of the buffer (lipoate = -290 mV) 
R gas constant (8.313 J/mol/K) 
T temperature (K) 
n number of electrons exchanged (2) 
F Faraday’s constant (96490 J/mol/V) 
 
Data Analysis 
Using SPSS (IBM, Armonk, New York), a repeated measures ANOVA was used to 
evaluate effects of hydrogen peroxide and Antimycin A treatments.  To evaluate the effects of 
treatment for each time point a one way ANOVA was performed (SPSS). A p value less than 0.05 
was taken as significant.  Using Prism (GraphPad, La Jolla, CA), a non-linear regression was 
used to generate a concentration response-curve and calculate the EC50 of H2O2.   
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CHAPTER 6 
Discussion 
 
The impact of ROS and mitochondrial dysfunction is gaining increased attention in many 
disease states involving the aberrant activity of sensory nerves.  Here, we evaluated the impact 
of mitochondrial modulation on the activation of TRPA1 and TRPV1 using CCCP, Rotenone, and 
Antimycin A.  Interestingly, all three inhibitors activated only a portion of nociceptive vagal neurons 
which express TRPA1 and/or TRPV1.  As vagal neurons are heterogenous, the lack/presence of 
a response mitochondrial modulation could be due to the presence of more than one neuronal 
subtype.  However, this is unlikely given that this same phenomenon was present in genetically 
identical transfected HEK293 cells.  Therefore, this lack of response in a portion of cells is likely 
due to mitochondrial metabolic status, or baseline cellular redox state.  Our co-imaging studies 
which simultaneously monitored mitochondrial function and ion channel activation demonstrated 
that many neurons that did not display evidence of channel activation exhibited substantial 
mitochondrial ROS production and mitochondrial depolarization.  This seems to indicate that 
numerous factors are involved in these responses.  Although activation of TRPA1 is ROS-
dependent, many neurons with substantial ROS production failed to exhibit a Ca2+ flux.  This 
seems to indicate that some preexisting cellular factor is responsible for sensitizing responses to 
mitochondrial modulation.  As TRPA1 is potentiated by Ca2+(Wang et al., 2008), mitochondrial 
Ca2+ release observed during mitochondrial depolarization may act to sensitize TRPA1 to ROS-
evoked activation.  Unfortunately, we are unable to study the combined impacts of mitochondrial 
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polarization, and ROS production on ion channel activation as co-imaging using three probes is 
not possible due to the overlap of excitation and emission fluorescence spectra.   
Although the mechanism underlying TRPV1 activation by mitochondrial modulation 
remains unknown, its activation is likely also affected by numerous factors as not all TRPV1 
expressing cells responded to mitochondrial modulation.  The regulation of TRPV1 is complex 
and involves many factors.  Therefore, several mechanisms may serve to activate TRPV1 
downstream of mitochondrial modulation.  The most likely being the PLC/PKC pathway which 
acts to sensitize TRPV1 through several mechanisms.  The PLC/PKC pathway is activated by 
inflammatory signaling, downstream of Receptor Tyrosine Kinases (RTK), and by antimycin 
A(Joseph and Levine, 2010; Wu et al., 2010b; Zhang et al., 2012).    Many inflammatory mediators 
result in the activation of PLC.  This results in the cleavage of PIP2 into DAG and IP3.  Not only 
does this release the constitutive inhibition of PIP2 on TRPV1, but it generates DAG, a TRPV1 
agonist(Woo et al., 2008; Cao et al., 2013).  Furthermore, mitochondrial depolarization can result 
in the activation of PLC.  The combined effects of PLC activation including the production of DAG 
and increased cytosolic Ca2+ can activate PKC, which has been shown to activate TRPV1(Lee et 
al., 2012; Wang et al., 2015).   Furthermore, antimycin A results in PKC activation and 
translocation to the cellular membrane(Wu et al., 2010b; Hadley et al., 2014).  Although this may 
occur through the activation of PLC, this may also occur through the production of ROS which 
activates non-canonical isoforms of PKC.  This mechanism explains the great variation in 
responses to mitochondrial modulation.  Many isoforms of PLC an PKC are present in vagal 
neurons.  As their expression is heterogeneous and they have differing substrate affinities, PLC 
and PKC expression in sensory nerve subsets may have an impact on TRPV1 activation. 
We gained many insights into the effects of mitochondrial function on the activation of 
TRPA1 and TRPV1.   However, much remains unknown and our studies are complicated by the 
issues regarding obtaining measurements of mitochondrial function.  One such issue is that the 
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use of mitochondrially targeted indicators such as MitoSOX and JC-1 can themselves induce 
mitochondrial dysfunction.  To minimize this, we used low dye concentrations, short loading times, 
and minimized the length of individual experiments.  Another potential problem is that the exact 
mechanisms by which ROS indicator dyes undergo oxidation is still under debate.  Although ROS 
sensitive probes exhibit specificities for individual ROS, the specificity of these probes is still under 
debate.  One reason for this being that these probes are oxidized in a different manner in situ 
than in vitro.  Another caveat of measurements in intact cells is that exact measurements of ROS 
production and mitochondrial depolarization can only be made in isolated mitochondria, not intact 
cells.  Therefore, measurements in intact cells are not exact and can only determine the extent of 
mitochondrial polarization and ROS production relative to baseline. 
Another complication regarding our studies is the identification of nociceptive neurons.  
The main reason for this is the heterogenous nature of vagal neurons.  As most nociceptors 
express TRPV1, TRPV1 is typically used to identify nociceptive neurons.  However, a small 
portion of nociceptors do not express TRPA1 or TRPV1.  In general, nociceptors are defined as 
being a population of sensory neurons which are activated by noxious stimuli(Sherrington, 1906).  
As such, they are inactive in healthy tissues and active in the presence of cellular damage and 
potential threats.  The specific set of activating stimuli for a single nociceptor is dependent on the 
expression of ion channels at the nerve terminal.  As the expression of these channels varies 
greatly, and identifications are somewhat ambiguous this complicates the identification of 
nociceptive neurons.  However, for our experiments devising a method for the identification was 
necessary as mitochondrial modulation evoked neuronal activation a subset of nociceptive 
neurons.  To aid in the identification of nociceptors which may not express TRPA1 or TRPV1, we 
used the VR1 CreRosa mouse model which expresses td Tomato in all cells which have ever 
expressed TRPV1 (TRPV1 lineage neurons).  Here, we identified nociceptors as neurons which 
exhibited a functional response to TRPA1 or TRPV1 agonists and/or express td Tomato (TRPV1 
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lineage neurons).  The VR1 CreRosa neurons allow for the identification of nociceptors in 
experiments using the TRPV1 inhibitor I-RTX which not wash off, preventing the functional 
responses to capsaicin typically used to identify TRPV1 expresion.  Unfortunately, VR1 CreRosa 
method for nociceptor identification is not available in KO mouse models.  In co-imaging 
experiments, we also used functional classifications of TRPA1 and TRPV1 expression as td 
Tomato fluorescence interferes with the visualization of JC-1 and MitoSOX. Therefore, we only 
used the functional responses to TRPV1 and TRPA1 agonists to identify nociceptors in co-
imaging and KO experiments.    Due to these complications regarding nociceptor classification, 
we did not perform statistics on the percentage of nociceptors which responded and only used 
these classifications in data visualization.   
A complication of these studies are the methods available to study ROS, which often have 
many caveats.  Therefore, we created a roGFP1 selenoprotein to increase the sensitivity of 
roGFP1 to ROS.  This roGFP1 selenoprotein which exhibited increased sensitivity to ROS as 
compared to roGFP1 as its 405/470 ratio was increased by lower concentrations of H2O2 (30nM) 
whereas the fluorescence of roGFP1 was unaltered.  Most importantly, the roGFP1 selenoprotein, 
but not roGFP1, responded during antimycin A treatment. Unfortunately, this protein exhibited a 
poor dynamic range and low expression due to the inefficiencies in selenocysteine incorporation.  
While we were able to measure the excitation and emission profile of the roGFP1 selenoprotein, 
we failed to generate sufficient material to perform a redox titration which may be in part due to 
protein degradation.  Unfortunately, the low expression of the roGFP1 selenoprotein coupled by 
its low dynamic range makes its practical use limited.  Therefore, other strategies must be used 
to develop improved genetically encoded ROS sensors and dyes to permit studies of ROS in 
disease states and cellular signaling.  If an increased understanding of the high reactivity of 
TRPA1 is gained, this mechanism may be exploited to increase the reactivity of the reactive 
cystines of roGFP1 and other genetically encoded redox sensing proteins.   
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CHAPTER 7 
Common Methods 
 
MOUSE MODELS 
Female TRPV1-/- mice were mated with male TRPV1-/- mice. Female TRPA1-/- mice were 
mated with male TRPA1+/- mice. Genotype of the offspring was confirmed using polymerase chain 
reaction. Wild type C57BL/6J mice were purchased from The Jackson Laboratory. For the VR1 
CreRosa mouse model, TRPV1-Cre mice(Cavanaugh et al., 2011) were crossed with Rosa-
tdTomato mice(Madisen et al., 2010).  All experiments were performed with approval from the 
University of South Florida Institutional Animal Care and Use Committee (AAALAC #000434). 
 
NEURONAL DISSOCIATION 
To obtain individual neurons on coverslips for live cell imaging experiments, we performed 
a neuronal dissociation.  Male 5-10 week old mice were euthanized via CO2 asphyxiation followed 
by exsanguination.  Heads (skin removed) were placed in chilled HBSS then transferred to a 
dissecting microscope.  Vagal ganglia (nodose and jugular) were dissected out and a nick placed 
in the outer layer to allow for penetration of the enzymes and placed in 2mL chilled, sterile-filtered 
HBSS with 2mg/mL collagenase and 2mg/mL Dispase I.  The ganglia were placed in a 37oC water 
bath for 30 minutes then triturated with a large bore and medium bore pipette and returned to the 
water bath for another 20 minutes.  After incubation, neurons were triturated with a small bore 
pipette then placed in the centrifuge and spun for 2 minutes at 700g.  Supernatant was removed, 
and neurons were resuspended in 10mL L-15 media centrifuged for 2 minutes at 700g.  This wash 
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was repeated once more using L-15 media with 5ul/mL pen/strep.  Neurons were then 
resuspended in 100ul L-15 + pen/strep and 20ul drops placed on the center of each of 5 PDL 
laminin coverslips inside of a 6 well plate.  Neurons were placed in an incubator and allowed to 
adhere for 1-2 hours before flooding with 2mL L-15 + 10% FBS.  Neurons were returned to the 
incubator and used within 24 hours. 
 
HEK293 CELL CULTURE 
HEK293 cells were used for functional analysis.  HEK239T cells were used for all other 
studies to maximize protein expression. Cells were lifted using Acutase and seeded onto poly-D 
lysine/laminin coverslips (live cell imaging), six well plates (roGFP western) or culture flasks 
(roGFP spectral analysis) and cultured in Dubecco’s modified Eagle’s medium containing 4.5g/L 
glucose, L-glutamine, and sodium pyruvate (Corning, Manassas, VA, REF:  10-013-CV).  The 
media was supplemented with 0.5% penicillin/streptomycin and 10% fetal bovine serum. Cells 
were transfected at 80% confluency cells using lipofectamine 2000 (Thermo Fisher Scientific, 
Waltham, MA).  Cells were allowed to incubate at 37oC with 5% CO2 and used within 36 hours. 
 
LIVE CELL IMAGING 
For live cell Ca2+ imaging experiments, cells were incubated with 4μM FURA-2AM for 30-
60 minutes at 37oC.  For co-imaging experiments, cells were incubated with 4μM FURA-2AM for 
30-60minutes before with 2μM 5,5′,6,6′-Tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine iodide 
(JC-1), or 5μM MitoSOX Red was added for the last 15 minutes of incubation.  Coverslips were 
loaded into a chamber on an inverted microscope and perfused with heated (33-34oC) HEPES 
buffer (154mM NaCl, 1.2mM KCl, 1.2mM MgCl2, 2.5mM CaCl2, 5.6mM D-Glucose).  Slides 
equilibrated for 10 minutes prior to the start of the experiment and if using the VR1 CreRosa 
neurons, an image was taken to visualize td Tomato fluorescence 535nm (excitation, emission at 
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610nm).  Changes in cytosolic Ca2+ was monitored using sequential excitation at 340nm and 
380nm (510nm emissions) with images taken every 6 seconds using a CoolSnap HQ2 camera 
(Photometerics, Surry, BC) and evaluated ratiometrically using the 340nm/380nm FURA-2 
fluorescence.  In co-imaging experiments, Fura-2AM imaging was followed by either MitoSOX 
Red imaging (mitochondrial O2- production) with excitation 535nm (emission at 610nm) or JC-1 
imaging (mitochondrial polarization) with 470nm (emission at 525nm and 610nm). 
All drugs were diluted in in HEPES buffer. Following 10μM antimycin A, 10μM CCCP, or 
5μM rotenone treatment, TRPA1 and TRPV1 expression was evaluated using the average 
cytosolic Ca2+ flux during 100μM AITC (TRPA1 agonist), and 1μM capsaicin (TRPV1 agonist) 
treatments (details regarding classification of neurons below).  In co-imaging experiments with 
FURA-2AM and JC-1 or MitoSOX, capsaicin and AITC were combined.  In live-cell co-imaging 
experiments of vagal neurons, capsaicin and AITC were combined to decrease experiment 
duration. This was followed by 75mM KCl (neuronal experiments only) to identify neurons and 
5μM ionomycin to evaluate the maximal Ca2+ response.   
 
IMAGE ANALYSIS 
Image analysis was performed by using Nikon Elements (Nikon, Melville, NY) by drawing 
individual regions of interest (ROI) that around the intracellular region for each neuron and tracked 
over time.  ROI’s with an unstable, high, or noisy baseline were eliminated from analysis.  Neurons 
which failed to exhibit an increase in [Ca2+]i either AITC, capsaicin or KCl challenges (> 30% the 
ionomycin maximal response) were eliminated. HEK293 cells failing to exhibit an increased [Ca2+]i 
in response to AITC (TRPA1 transfected) or capsaicin (TRPV1 transfected) were omitted.  
Relative changes in [Ca2+]i were determined ratiometrically (R) using Fura-2 fluorescence: 
340nm/380nm as to negate the impact of cell to cell variations in FURA-2AM loading.  In the time 
series analyses, changes in the 340/380 ratio (ΔR = R1—R0) are presented.  Antimycin A 
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responses were calculated using the maximal change in the 340/380 ratio (see Calculation of 
responses to mitochondrial modulation).    
 
CLASSIFICATION OF VAGAL NEURONS 
Methods are adapted from Stanford and Taylor-Clark 2018(Stanford and Taylor-Clark, 
2018). The average Ca2+ flux during AITC and capsaicin (chapters 1 and 3) or combined 
AITC/capsaicin (chapter 2) treatments were used to classify neuronal expression of TRPA1 and 
TRPV1.   Responses were classified as follows: 
 
 
The functional responses (Ca2+ fluxes) to capsaicin and AITC were used to classify TRPA1 
and TRPV1 expression.  This method allows for the classification of most, but not all, nociceptors 
as nociceptors.  The reason for this is the heterogenous nature of vagal neurons and the 
expression of TRPA1 and TRPV1 on most but not all nociceptors.   Unfortunately, this lack of 
TRPA1 and TRPV1 expression complicates the identification of nociceptors.  Therefore, when 
available we used the VR1 CreRosa mouse model which expresses td Tomato in all neurons 
which have ever expressed TRPV1.  This allows for the identification of TRPV1 lineage neurons 
by visualizing td Tomato fluorescence.  Furthermore, this model is also useful in experiments 
using the TRPV1 inhibitor I-RTX as it does not wash off, preventing the identification of TRPV1 
expression using functional classifications.  In chapter 1, we characterized this mouse model and 
found that 61% of neurons (n = 68) expressed td Tomato expressed TRPV1 and/or TRPA1, 17% 
of neurons (n = 21) were td Tomato positive and did not express TRPV1 and/or TRPA1 and 4% 
 
RAITC/Caps > (Rbl + 2*SDbl) 
RAITC/Caps average 340/380 ratio during AITC/capsaicin treatment 
Rbl baseline 340/380 ratio prior to treatment 
SDbl standard deviation of Rbl 
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of neurons were td Tomato negative and expressed TRPA1 and/or TRPV1.  As we classified 
nociceptors as the population of neurons which expresses td Tomato, TRPA1 and/or TRPV1, this 
results in approximately 82% of neurons being classified as nociceptive.   
In studies of mitochondrial inhibitors on the Ca2+ fluxes in vagal neurons, we found that 
mitochondrial modulation evoked plasma membrane ion channel activation in a portion of 
nociceptive, but not non-nociceptive neurons.  This underscores the importance of the proper 
identification of nociceptive neurons.  Unfortunately, this the VR1 CreRosa mouse model was not 
available for all experiments as td Tomato fluoresce interferes with visualization of MitoSOX Red 
and JC-1 and it is not available in KO models.  Therefore, in these experiments we relied on 
functional classifications of TRPV1 and TRPA1 expression.  In experiments where the VR1 
CreRosa mouse model was available, we used the above method to classify nociceptors 
(nociceptive versus non-nociceptive) whereas when this model was not available, we did not 
identify neurons as nociceptive and relied on evaluating TRPA1 and TRPV1 expression using 
functional responses to agonists (A1/V1+ versus A1/V1-).   
 
CALCULATION OF RESPONSES TO MITOCHONDRIAL MODULATION 
In the bar graphs, scatterplots and statistical analyses we used maximal responses to 
mitochondrial modulation expressed as the maximal change in the 340/340 ratio during three-
minute treatment with mitochondrial modulators (ΔRmax).  In our experiments, only a portion of 
neurons responded.  These responses were isolated to nociceptive neurons, many of which 
express TRPA1 and/or TRPV1.  Unfortunately, nociceptor classification is complicated by the 
heterogenous nature of vagal neurons.  While most express TRPA1 and/or TRPV1, many do not.  
Due to the individual requirements of each experiment and our ability to use the VR1 CreRosa 
mouse model, we classified neurons using two methods (see nociceptor classifications) one 
which classified neurons as nociceptive or nonnociceptive and the other which classified neurons 
83 
 
based on TRPA1/TRPV1 expression.  Therefore, we defined responses to mitochondrial 
modulation based on either the nonnociceptive population or the A1/V1- population as follows: 
 
 
Using the above calculations, we were able to classify neurons based on their response 
vs. nonresponse to mitochondrial modulation.  This allowed for the evaluation of the percentage 
of responding neurons and magnitude of the Ca2+ flux in responding neurons.  In HEK293 cells 
the response vs. non-response classifications were not used.   Therefore, in experiments using 
HEK293 cells, only the maximal responses to mitochondrial modulation across all cells were 
evaluated. 
 
 
 
 
 
 
 
 
ΔRmax(noci)>ΔRmax(noci)+3*SD(nonnoci) 
ΔRmax(noci) maximal response in a single nociceptor 
ΔRmax(nonnoci) average maximal response in non-nociceptors 
SD(nonnoci) standard deviation of ΔRmax(nononoci) 
 
NOTE:  For experiments using expressional classification of TRPA1/TRPV1, A1/V1+ was used 
in place of nociceptive neurons and A1/V1- was used in the place of nonnociceptive 
neurons. 
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